ΚΑΤΑΛΟΓΟΣ ΔΗΜΟΣΙΕΥΣΕΩΝ

ΣΥΓΓΡΑΦΙΚΟ ΕΡΓΟ
ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΕΓΚΡΙΤΑ ΔΙΕΘΝΗ ΕΠΙΣΤΗΜΟΝΙΚΑ ΠΕΡΙΟΔΙΚΑ ΜΕ ΚΡΙΤΕΣ
Δημοσιευμένα σε PUBMED/MEDLINE, Google Scholar & Web of Science

1. Galateia Stathori, Kyriaki Hatziagapiou, George Mastorakos, Nikolaos F. Vlahos, Evangelia Charmandari and Georgios Valsamakis
Endocrine-Disrupting Chemicals, Hypothalamic Inflammation
and Reproductive Outcomes: A Review of the Literature
Int. J. Mol. Sci. 2024, 25, 11344.
https://doi.org/10.3390/ ijms252111344
SJR 1.18; Q1 Impact factor 4.9

2. Eleni Koniari, Kyriaki Hatziagapiou, Alexandra Olti Nikola, Konstantina Georgoulia, Nikolaos Marinakis, Petros Bakakos, Athanasia Athanasopoulou, Athanasios Koromilias, Nikoletta Rovina, Vasiliki Efthymiou, Eleni Papakonstantinou, Dimitrios Vlachakis, Sophia Mavrikou, Antonia Koutsoukou, Joanne Traeger-Synodinos, George P Chrousos
ENaC gene variants and their involvement in Covid‑19 severity
Biomed Rep. 2024 Sep 25;21(6):176. doi: 10.3892/br.2024.1864. eCollection 2024 Dec
SJR 0.514; Q1 Impact factor 2.3

3. Golfinopoulou R, Hatziagapiou K, Mavrikou S, Kintzios S.
Unveiling Colorectal Cancer Biomarkers: Harnessing Biosensor Technology for Volatile Organic Compound Detection.
Sensors (Basel). 2024 Jul 20;24(14):4712. doi: 10.3390/s24144712.
SJR 0.79; Q1 Impact factor 3.4

4. Apostolos Apostolakis, Dimitris Barmpakos, Sofia Mavrikou, George Marios Papaionannou, Vasileios Tsekouras, Kyriaki Hatziagapiou, Eleni Koniari, Maroula Tritzali, Athanasios Michos, George P. Chrousos, Christina Kanaka-Gantenbein, Grigoris Kaltsas, Spyridon Kintzios
System for classifying antibody concentration against severe acute respiratory syndrome coronavirus 2 S1 spike antigen with automatic quick response generation for integration with health
passports
Explor Digit Health Technol. 2024; 2:20–9 https://doi.org/10.37349/edht.2024.00008

5. E. Kakouri, K. Hatziagapiou, Ch. Kanakis, O. Nikola, G. I. Lambrou, P. Trigas 4, Ch. Kanaka-Gantenbein, and P. A. Tarantilis
Cytotoxic and Antioxidant Activity of a Chemically Characterized Extract of Smilax aspera Leaves and Stems
Appl. Sci. 2023 13(8), 4784;
https://doi.org/10.3390/app13084784
SJR 0.51; Q2 Impact factor 2.838

6. E. Kakouri, O. Nikola, Ch. Kanakis, K. Hatziagapiou, G.I. Lambrou, P. Trigas, Ch. Kanaka-Gantenbein, P. A. Tarantilis
Cytotoxic Effect of Rosmarinus officinalis Extract on Glioblastoma and Rhabdomyosarcoma Cell Lines
Molecules 2022, 27(19), 6348;
https://doi.org/10.3390/molecules27196348
SJR 0.71; Q1 Impact factor 4.927

7. S. Mavrikou, G.M. Papaioannou, V. Tsekouras, K. Hatziagapiou, Elizabeth B. Tatsi, F. Filippatos, C. Kanaka-Gantenbein, A. Michos, and S. Kintzios
Ultra-Fast and Sensitive Screening for Antibodies against the SARS-CoV-2 S1 Spike Antigen with a Portable Bioelectric Biosensor
Chemosensors 2022, 10 (7), 254;
https://doi.org/10.3390/chemosensors10070254
SJR 0.63; Q1 Impact factor 4.229

8. K. Hatziagapiou, Olti Nikola, S. Marka, E. Koniari, E. Kakouri, M.-E. Zografaki, S. S. Mavrikou, Ch. Kanakis, E. Flemetakis, G. P. Chrousos, S. Kintzios, G.I. Lambrou, C. Kanaka-Gantenbein, and P. A. Tarantilis
An In Vitro Study of Saffron Carotenoids: The Effect of Crocin Extracts and Dimethylcrocetin on Cancer Cell Lines
Antioxidants 2022, 11(6): 1074;
https://doi.org/10.3390/antiox11061074 PMID:35739971
SJR 1.01; Q1 Impact factor 7.675

9. Hatziagapiou K, Bethanis K, Koniari E, Christoforides E, Nikola O, Andreou A, Mantzou A, Chrousos GP, Kanaka-Gantenbein C, Lambrou GI.
Biophysical Studies and In Vitro Effects of Tumor Cell Lines of Cannabidiol and Its Cyclodextrin Inclusion Complexes.
Pharmaceutics 2022; 14(4):706. https://doi.org/10.3390/pharmaceutics14040706 PMID: 35456540
SJR 1.05; Q1 Impact factor 6.525

10. Sofia Mavrikou, Vasileios Tsekouras, Kyriaki Hatziagapiou, Asimina Tsalidou, Petros Bakakos, Nikoletta Rovina, Antonia Koutsoukou, Athanasios Michos, Olti Nikola, Eleni Koniari, Joseph Papaparaskevas, George P. Chrousos, Christina Kanaka-Gantenbein and Spyridon Kintzios.
Angiotensin-Converting Enzyme 2 (ACE2) As a Novel Biorecognition Element in A Cell-Based Biosensor for the Ultra-Rapid, Ultra-Sensitive Detection of the SARS-CoV-2 S1 Spike Protein Antigen
Chemosensors 2021, 9(12), 341.
https://doi.org/10.3390/chemosensors9120341
SJR 0.63; Q1 Impact factor 4.229

11. Maria Braoudaki, Kyriaki Hatziagapiou, Apostolos Zaravinos, George I. Lambrou.
MYCN in Neuroblastoma: “Old Wine into New Wineskins”
Diseases 2021; 9, 78.
https://doi.org/10.3390/diseases9040078 PMID: 34842635
SJR 0.819 Q1

12. Sophie Mavrikou, Vasileios Tsekouras, Kyriaki Hatziagapiou, Foteini Paradeisi, Petros Bakakos, Athanasios Michos, Antonia Koutsoukou, Elissavet Konstantellou, George I. Lambrou, Eleni Koniari, Elizabeth-Barbara Tatsi, Joseph Papaparaskevas, Dimitrios Iliopoulos, George P. Chrousos, Spyridon Kintzios
Clinical Application of the Novel Cell-Based Biosensor for the Ultra-Rapid Detection of the SARS-CoV-2 S1 Spike Protein Antigen: A Practical Approach.
Biosensors 2021; 11 (7): 224
https://doi.org/10.3390/bios11070224
SJR 0.91; Q2 -Impact factor 5.743

13. Lambrou GI, Hatziagapiou K, Zaravinos A.
The Non-Coding RNA GAS5 and Its Role in Tumor Therapy-Induced Resistance.
Int J Mol Sci. 2020 Oct 15;21(20):7633.
doi: 10.3390/ijms21207633 PMID: 33076450 PMID: 34356695
SJR 1.32; Q1 -Impact factor 6.208

14. Constantina Politis, Clive Richardson, Helen Hassapopoulou-Matamis, Lida Politi, Kyriaki Hatziagapiou, Elisavet Grouzi, George Bollas, Vassilios Soulakis, Sotirios Pagonis, Efrosini Nomikou, Eleftherios Constantinidis1 & Eleftheria Zervou
Strategies for blood collection and optimization of the blood supply chain during the COVID-19 pandemic in Greece
ISBT (International Society of Blood Transfusion) Science SeriesVox Sanguinis 2020; 15(4): 386–392
DOI: 10.1111/voxs.12607
SJR 1.32; Q1 – Impact factor 2.996

15. George I. Lambrou, Kyriaki Hatziagapiou & Spiros Vlahopoulos
Inflammation and tissue homeostasis: the NF-κB system in physiology and malignant progression
Molecular Biology Reports 2020; 47 (5): 4047–4063
https://doi.org/10.1007/s11033-020-05410-w PMID: 32239468
SJR 0.47; Q2 – Impact factor 2.742

16. Kyriaki Hatziagapiou, Tomoshige Kino, George I. Lambrou
The Non-Coding RNA Repressor GAS5 of the Glucocorticoid Receptor: Insights to its Role in Human Malignancies
MedOne 2020; 5 (2): e200003
https://doi.org/10.20900/mo20200003

17. George I. Lambrou, Maria Adamaki, Spiros Vlahopoulos, Kyriaki Hatziagapiou.
Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update.
Current Drug Research Reviews 2020; 12(2): 131 – 149.
DOI: 10.2174/2589977512666200220122650. PMID: 32077838
SJR 0.81; Q2 – Impact factor 2.4

18. George I. Lambrou, Kyriaki Hatziagapiou, Petros Toumpaniaris, Penelope Ioannidou and Dimitrios Koutsouris
Computational Modelling in Epidemiological Dispersion Using Diffusion and Epidemiological Equations: Epidemiological Dispersion Modelling.
International Journal of Reliable and Quality E-Healthcare (IJRQEH) 2019; 8(4):1-37.
DOI: 10.4018/IJRQEH.2019100101
Impact factor 1

19. Iason Theodoridis, Kyriaki Hatziagapiou, George I. Lambrou
On the Physicochemical Properties of Biological Systems: Cells and Fluids of the Central Nervous System.
Journal of Biological Physics and Chemistry. 2020; 20(2): 68-85
DOI: 10.4024/25TH19R.jbpc.20.02

20. Chrysoula Argyrou, Kyriaki Hatziagapiou, Margarita Theodorakidou, Olti Alexandra Nikola, Spiros Vlahopoulos and George I. Lambrou.
The Role of Adiponectin, Leptin and Ghrelin in the progress and prognosis of childhood Acute Lymphoblastic Leukemia.
Leukemia and Lymphoma 2019; 60(9): 2158-2169
DOI: 10.1080/10428194.2019.1569230; PMID: 30696312.
SJR 1.013; Q2- Impact factor 3.280

21. Kyriaki Hatziagapiou, Eleni Kakouri, George I. Lambrou, Eleni Koniari, Charalabos Kanakis, Olti Alexandra Nikola, Margarita Theodorakidou, Konstantinos Bethanis and Petros A. Tarantilis.
Crocins, the Active Constituents of Crocus Sativus L. Stigmas, Exert Significant Cytotoxicity on Tumor Cells In Vitro.
Current Cancer Therapy Reviews 2019; 15 (3): 225-234
DOI:10.2174/1573394714666181029120446
SJR 0.14; Q4 – Impact factor 0.364

22. George I. Lambrou and Kyriaki Hatziagapiou
Anti-toxicant Properties of Saffron and Relevance to Protection from Toxins and Drugs.
Current Bioactive Compounds 2020; 16(3): 265 – 283
DOI: 10.2174/1573407214666181003123707
SJR 0.269; Q2- Impact factor 1.6

23. Hatziagapiou K, Lambrou GI.
The Protective Role of Crocus Sativus L. (Saffron) Against Ischemia- Reperfusion Injury, Hyperlipidemia and Atherosclerosis: Nature Opposing Cardiovascular Diseases.
Current Cardiology Reviews 2018;14(4):272-289
DOI: 10.2174/1573403×14666180628095918; PMID: 29952263.
SJR 0.815; Q2 – Impact factor 3.3

24. Hatziagapiou K, Kakouri E, Lambrou GI, Bethanis K, Tarantilis PA. Antioxidant Properties of Crocus Sativus L. and its Constituents and Relevance to Neurodegenerative Diseases; Focus on Alzheimer’s and Parkinson’s disease.
Current Neuropharmacology 2019; 17(4):377-402
DOI: 10.2174/1570159X16666180321095705; PMID: 29564976.
SJR 1.53; Q1- Impact factor 9.589

25. Kyriaki Hatziagapiou, Eleni Kakouri, Kostas Bethanis, Olti Alexandra Nikola, George I. Lambrou, & Petros A. Tarantilis.
Tumor-Suppressing Properties of Crocus sativus L.: Nature as an Anti-Cancer Agent.
Critical Reviews in Oncogenesis 2017;22(3-4):263-273
DOI: 10.1615/CritRevOncog.2017024841; PMΙD: 29604903
SJR 0.946; Q3- Impact factor 3

26. Kyriaki Ηatziagapiou, Konstantinos Bethanis, George I. Lambrou, Konstantina Yannakopoulou, Michael Karpusas, Maria Braoudaki, Elias Christoforides, Frantzeska Tsorteki, Vasilis Milionis, Nikolaos Kavantzas, Fotini Tzortzatou-Stathopoulou, Vasiliki Gemou-Engesaeth.
Εnhanced gefitinib cytotoxicity in the presence of cyclodextrins: in-vitro and biophysical studies towards potential therapeutic interventions for cancer .
Journal of Biomedical Nanotechnology 2017;13(5): 522-533
DOI: 10.1166/jbn.2017.2374
SJR 0.916; Q1- Impact factor 7.834.

27. Hatziagapiou K., Braoudaki M., Karpusas M., Tzortzatou-Stathopoulou F..
Antitumor activity of gefitinib in glioblastoma and neuroblastoma cells.
Clinical Laboratory 2011; 57:781-784; PMID: 22029196
SJR 0.419; Q2 – Impact factor 1.345.

ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΕΛΛΗΝΙΚΑ ΕΠΙΣΤΗΜΟΝΙΚΑ ΠΕΡΙΟΔΙΚΑ ΜΕ ΚΡΙΤΕΣ
Δημοσιευμένα σε Google Scholar

1. Κυριακή Χατζηαγαπίου, Μαργαρίτα Θεοδωρακίδου, Όλτι Αλεξάνδρα Νικόλα, και Γεώργιος I. Λάμπρου. Η αγγείωση του ήπατος και ο ρόλος της στις παιδιατρικές ηπατικές νεοπλασίες.
Δελτίο Α’ Παιδιατρικής Κλινικής Πανεπιστημίου Αθηνών, 2018;68(3):8-18.

2. Μαργαρίτα Θεοδωρακίδου, Κυριακή Χατζηαγαπίου, Όλτι Αλεξάνδρα Νικόλα, Γεώργιος Λάντις και Γεώργιος I. Λάμπρου. Νεότερα δεδομένα στο ρόλο της αδιπονεκτίνης, λεπτίνης και γκρελίνης στην αιτιολογία και παθογένεση της παιδικής παχυσαρκίας.
Δελτίο Α’ Παιδιατρικής Κλινικής Πανεπιστημίου Αθηνών, 2017;67(4):26-43.

ΠΡΩΤΟΤΥΠΕΣ ΕΡΕΥΝΗΤΙΚΕΣ ΕΡΓΑΣΙΕΣ ΣΕ ΣΥΛΛΟΓΙΚΟΥΣ ΤΟΜΟΥΣ ΔΙΕΘΝΩΝ ΣΥΝΕΔΡΙΩΝ ΜΕ ΚΡΙΤΕΣ (CONFERENCE PAPERS)
Δημοσιευμένα σε PUBMED/MEDLINE, Google Scholar & Web of Science

1. George Lambrou, Maria Adamaki, Kyriaki Hatziagapiou, S Geronikolou, Athanasios Tsartsalis and Spiros Vlahopoulos
Early and Very Early GRIM19 and MCL1 Expression are Correlated to Late Acquired Prednisolone Effects in a T-Cell Acute Leukemia Cell Line
Proceedings of the 4th World Congress on Genetics, Geriatrics, and Neurodegenerative Disease Research (GeNeDis 2020) “Health in Aging and Mental Wellness in the new digital era”.
Adv Exp Med Biol. 2021; 1339:147-160
8-10 October 2020; Athens, Greece;
DOI:10.1007/978-3-030-78787-5_20 ;PMID 35023102
SJR 0.4; Q3 – Impact factor 3.650

2. Kyriaki Hatziagapiou, Maria Braoudaki, Kostas Bethanis, Konstantina Yannakopoulou, Athanasios Anastasiou, Georgia Koutsouri, Dimitrios Koutsouris, George I. Lambrou. (2018)
Computational Analysis of Gefitinib and Methylated-Hydroxypropylated Cyclodextrin Inclusion Complexes for the Treatment of Childhood Malignancies.
Proceedings of the IEEE EMBS 2018 International Conference on Biomedical & Health Informatics (BHI); 4-7 March 2018, Las Vegas, Nevada, USA; pp. 194-197.
DOI: 10.1109/BHI.2018.8333402
SJR 1.593; Q1

ΠΡΩΤΟΤΥΠΕΣ ΕΡΕΥΝΗΤΙΚΕΣ ΕΡΓΑΣΙΕΣ ΣΕ ΣΥΛΛΟΓΙΚΟΥΣ ΤΟΜΟΥΣ ΕΛΛΗΝΙΚΩΝ ΣΥΝΕΔΡΙΩΝ ΜΕ ΚΡΙΤΕΣ (CONFERENCE PAPERS)
Δημοσιευμένα σε Google Scholar & Web of Science

1. Kostas Bethanis, Elias Christoforides, Konstantina Yannakopoulou, Kyriaki Ηatziagapiou, Maria Braoudaki, Frantzeska Tsorteki, George I. Lambrou, Fotini Tzortzatou-Stathopoulou, Vasiliki Gemou-Engesaeth and Michael Karpusas (2016)
Structure and anti-proliferative activity of gefitinib-cyclodextrin complexes.
Proceedings of the Joint Conference of the Hellenic Crystallographic Association and the Hellenic Society for Computational Biology and Bioinformatics (HECRA-HSCBB16); 07-09 October 2016, Agricultural University of Athens, Athens, Greece; pp 51.

ΠΕΡΙΛΗΨΕΙΣ ΣΕ ΠΡΑΚΤΙΚΑ ΔΙΕΘΝΩΝ ΣΥΝΕΔΡΙΩΝ ΜΕ ΚΡΙΤΕΣ (PEER-REVIEWED ABSTRACTS)-
ΔΗΜΟΣΙΕΥΣΗ ΣΕ ΣΥΜΠΛΗΡΩΜΑΤΙΚΑ ΤΕΥΧΗ ΔΙΕΘΝΩΝ ΠΕΡΙΟΔΙΚΩΝ
Δημοσιευμένα σε PUBMED/MEDLINE, Google Scholar & Web of Science

1. Kyriaki Hatziagapiou, Danai Georgakopoulou,,Anastasia Polytarchou, Aggeliki Moudaki,,Christina Kanaka-Gantenbein, Sophia D Sakka
AFMS (Achondroplasia Foramen Magnum Score) in a case series; correlation with clinical manifestations, and sleep studies
Horm Res Paediatr (2024) 97 (Suppl. 3): pp.295
https://doi.org/10.1159/000541189
SJR 0,84; Q1 Impact Factor: 3.2

2. Kyriaki Hatziagapiou, Maria Dolianiti, Sofia D. Sakka, Eleftheria Kokkinou, Roser Pons, Christina Kanaka-Gantenbein
X-linked adrenoleukodystrophy in two male siblings; endocrinological aspects of the disease, and therapeutic approaches
Horm Res Paediatr (2024) 97 (Suppl. 3): pp.328
https://doi.org/10.1159/000541189
SJR 0,84; Q1 Impact Factor: 3.2

3. Kyriaki Hatziagapiou, Amalia Sertedaki, Vasiliki Dermentzoglou, Christina Kanaka-Gantenbein, Sophia D. Sakka
Kenny Caffey syndrome 2; a rare cause of hypoparathyroidism, and short stature.
JBMR Plus 2024, 8 (Suppl. 2): iiii354
https://doi.org/10.1093/jbmrpl/ziae105
SJR 1,13; Q1 Impact Factor: 3.4

4. I.-A. Vasilakis, D. Georgakopoulou, K. Hatziagapiou, S. Sakka, E. Angelopoulou, M. Dolianiti, M. Binou, I. Farakla, M. Nikolaou, D. Barlampa, A. Tsigkri, I. Gkika, E. Kotsi, I. Tokou, N.C. Nicolaides, C. Kanaka- Gantenbein
Sustained improvement of glycemic control in children and adolescents with type 1 diabetes mellitus, 12 months after transitioning from multiple daily injections (MDI) to advanced hybrid closed loop (aHCL), without significant change in BMI-SDS
Horm Res Paediatr 10/2024 97 (Suppl. 2): 5–371. https://doi.org/10.1159/000541195
SJR 0,84; Q1 Impact Factor: 3.2

5. Kyriaki Hatziagapiou, Eleni Koniari, Vasiliki Efthymiou, Konstantina K. Georgoulia, Dario Boschiero, Sophie S Mavrikou, Spyridon Kintzios, George P Chrousos
Photoplethysmography And Bioimpedence Indices as indicators of current and future health in overweight and obese children
Diabetes Technology & Therapeutics 2024 26:S2, A-1-A-376
https://doi.org/10.1089/dia.2024.2525.abstract
SJR 2,96; Q1 Impact Factor: 5.7

6. Kyriaki Hatziagapiou, Ioannis- Anargyros Vasilakis, Maria Binou, Maria Dolianiti, Nicolas C. Nicolaides, Emmanouil Zoumakis, Chryssanthi Papathanasiou, Eleni Gkougkouli, Konstantina Barouti, Christina Kanaka-Gantenbein, Sophia D. Sakka
The awakening of the hypothalamic-pituitary-gonadal axis in the post-COVID era; the Greek experience.
Hormone Research in Paediatrics. 9/2023; 96 (Suppl. 4): pp. 362.
https://doi.org/10.1159/000533803
SJR 0,84; Q1 Impact Factor: 3.2

7. Kyriaki Hatziagapiou, Amalia Sertedaki, Vasiliki Dermentzoglou, Christina Kanaka- Gantenbein, Sophia D. Sakka
Kenny Caffey syndrome 2; expanding the clinical spectrum
Hormone Research in Paediatrics. 9/2023; 96 (Suppl. 4): pp. 480.
https://doi.org/10.1159/000533803
SJR 0,84; Q1 Impact Factor: 3.2

8. Eleni Koniari, Kyriaki Hatziagapiou, Anastasia Skouma, Fotis Chaliotis, Panagiota Drosatou, Evelina Tsani, Vasiliki Blatsa, George Chrousos
Genetic evidence for a causal relationship between severe hyperlipidemia and Type 1 Diabetes
Hormone Research in Paediatrics. 9/2023; 96 (Suppl. 4): pp. 502.
https://doi.org/10.1159/000533803
SJR 0,84; Q1 Impact Factor: 3.2

9. Kyriaki Hatziagapiou, Olti Nikola, Eleni Kakouri, George
Lambrou, Eleni Koniari, Christina Kanaka-Gantenbein, Petros Tarantilis.
Integrating Saffron Metabolomics into the treatment of pediatric cancers
Archives of Disease in Childhood 10/2021; 106 (S2): pp. A133-134;
DOI: 10.1136/archdischild-2021-europaediatrics.315
SJR 1.04; Q1 Impact Factor: 3.791

10. Kyriaki Hatziagapiou, Konstantinos Bethanis, Olti Nikola, Elias
Christoforides, Eleni Koniari, Eleni Kakouri, George Lambrou, Christina Kanaka- Gantenbein.
Integrating non psychoactive phytocannabinoids and their, cyclodextrin inclusion complexes into the treatment of neuroblastoma
Archives of Disease in Childhood 10/2021; 106 (S2): pp. A133-134;
DOI: 10.1136/archdischild-2021-europaediatrics.316
SJR 1.04; Q1 Impact Factor: 3.791

11. Kyriaki Hatziagapiou, Olti Nikola, Eleni Kakouri, George Lambrou, Konstantinos Bethanis, Elias Christoforides, Eleni Koniari, P. Tarantilis, Christina Kanaka- Gantenbein.
Integrating non-psychoactive phytocannabinoids and their cyclodextrin inclusion complexes into the treatment of pediatric cancers
Pediatric Blood & Cancer 11/2021; 68(S5):pp S227
https://doi.org/10.1002/pbc.29395
SJR 1.12; Q1 Impact factor:3.167

12. Kyriaki Hatziagapiou, Olti Nikola, Eleni Kakouri, George Lambrou, Eleni Koniari, Christina Kanaka- Gantenbein, P. Tarantilis.
Integrating saffron metabolomics into medulloblastoma treatment
Pediatric Blood & Cancer 11/2021; 68(S5):pp S511
https://doi.org/10.1002/pbc.29395
SJR 1.12; Q1 Impact factor:3.167

13. Kyriaki Hatziagapiou, Konstantinos Bethanis, Olti Nikola, Elias
Christoforides, Eleni Koniari, Eleni Kakouri, George Lambrou, Christina Kanaka-Gantenbein
Integrating Non-Psychoactive Phytocannabinoids and Their Cyclodextrin Inclusion Complexes into the Treatment of Glioblastoma
International Journal of Pharmacological and Pharmaceutical Sciences 2021; 15(4)

14. Kyriaki Hatziagapiou, Eleni Kakouri, Konstantinos Bethanis, Alexandra Nikola, Eleni Koniari, Charalabos Kanakis, Elias Christoforides, George Lambrou, Petros Tarantilis.
Inhibitory Effects of Crocin from Crocus Sativus L. on Cell Proliferation of a Medulloblastoma Human Cell Line.
International Journal of Medical and Health Sciences 2017 11(12)
DAI: http://dai.waset.org/1307-6892/80420.

15. Kiriaki Hatziagapiou, Eleftheria Kaiafa,Paraskevi Zosi, Dionisis Karakaidos, Soultana Georga, Thomais Vlahou, Likourgos Kanaris, Georgios Kafalidis.
Growth hormone treatment to final height in children with idiopathic short stature: evidence for an early therapy initiation effect.
Hormone Research in Paediatrics. 9/2014; 82 (S1): pp. 253.
DOI: 10.1159/000365775; PMΙD: 25247597.
SJR 0,878; Q1 Impact Factor: 4.275

16. Kyriaki Hatziagapiou, Maria Braoudaki, George I. Lambrou, Franzeska Tsorteki, Fotini Tzortzatou-Stathopoulou, Konstantinos Bethanis, Vasilki Gemou-Engesaeth.
Clinical Uses of Gefitinib/Cyclodextrin Inclusion Complexes; Physicochemical Approaches and Potential Novel Cancer Therapeutic Interventions.
Neuro-Oncology, 16(S1);1 June 2014: I137–I145; Tumor Biology (TB-028);
https://Doi.Org/10.1093/Neuonc/Nou082 ; PMΙD: 24904003
SJR 4.24; Q1 Impact Factor: 12.3

17. Kafalidis G., Zosi P., Salapata A., Hatziagapiou K., Zaharia T., Isaakidou Ε., Karis Ch.
Final height in Growth Hormone deficient children.
Hormone Research in Paediatrics. 9/2010;74 (S3): pp. 274.
DOI: 10.1159/000321348; PMID: 22001932.
SJR 0,878; Q1 Impact Factor: 4.275

18. Karakaidos D., Kafalidis G., Patsourou E., Zosi P., Salapata A., Hatziagapiou K., Karis Ch.
Cushing’s Syndrome due to topical corticosteroids absorption. Hormone Research in Paediatrics. 9/2010;74 (S3): pp. 260.
DOI: 10.1159/000321348; PMID: 22001932.
SJR 0,878; Q1 Impact Factor: 4.275

ΠΕΡΙΛΗΨΕΙΣ ΣΕ ΠΡΑΚΤΙΚΑ ΔΙΕΘΝΩΝ ΣΥΝΕΔΡΙΩΝ ΜΕ ΚΡΙΤΕΣ (PEER-REVIEWED ABSTRACTS)-
ΔΗΜΟΣΙΕΥΣΗ ΣΕ ΠΡΑΚΤΙΚΑ ΔΙΕΘΝΩΝ ΣΥΝΕΔΡΙΩΝ (CONFERENCE ABSTRACT PROCEEDINGS)
Δημοσιευμένα σε Google Scholar

1. Kyriaki Hatziagapiou, Danai Georgakopoulou,,Anastasia Polytarchou, Aggeliki Moudaki,,Christina Kanaka-Gantenbein, Sophia D Sakka
AFMS (Achondroplasia Foramen Magnum Score) in a case series; correlation with clinical manifestations, and sleep studies
62nd Annual Meeting of the European Society for Paediatric Endocrinology (ESPE); Liverpool, United Kingdom, November 16–18, 2024

2. Kyriaki Hatziagapiou, Maria Dolianiti, Sofia D. Sakka, Eleftheria Kokkinou, Roser Pons, Christina Kanaka-Gantenbein
X-linked adrenoleukodystrophy in two male siblings; endocrinological aspects of the disease, and therapeutic approaches
62nd Annual Meeting of the European Society for Paediatric Endocrinology (ESPE); Liverpool, United Kingdom, November 16–18, 2024

3. Kyriaki Hatziagapiou, Amalia Sertedaki, Dermentzoglou Vasiliki, Christina Kanaka-Gantenbein, Sophia D. Sakka
Kenny Caffey syndrome 2; a rare cause of hypoparathyroidism, and short stature
11th International Conference on Children’s Bone Health -ICCBH 2024, Salzburg; Austria, 22-25/6/2024

4. I.-A. Vasilakis, D. Georgakopoulou, K. Hatziagapiou, S. Sakka, E. Angelopoulou, M. Dolianiti, M. Binou, I. Farakla, M. Nikolaou, D. Barlampa, A. Tsigkri, I. Gkika, E. Kotsi, I. Tokou, N.C. Nicolaides, C. Kanaka- Gantenbein
Sustained improvement of glycemic control in children and adolescents with type 1 diabetes mellitus, 12 months after transitioning from multiple daily injections (MDI) to advanced hybrid closed loop (aHCL), without significant change in BMI-SDS
ISPAD 2024 Inclusion and innovation in pediatric; Lisbon, Portugal; October 16-19, 2024

5. Kyriaki Hatziagapiou, Eleni Koniari, Vasiliki Efthymiou, Konstantina K. Georgoulia, Dario Boschiero, Sophie S Mavrikou, Spyridon Kintzios, George P Chrousos
Photoplethysmography And Bioimpedence Indices as indicators of current and future health in overweight and obese children
ATTD Advanced Technologies & Treatments for Diabetes Conference 6–9 March 2024, Florence

6. I.-A. Vasilakis, S. Sakka, E. Angelopoulou, K. Hatziagapiou, D. Georgakopoulou, K. Barouti, M. Dolianiti, M. Binou, I. Farakla, N. Nicolaides, C. Kanaka- Gantenbein
Rapid improvement of glycemic control in children and adolescents with type 1 diabetes mellitus, after transitioning from multiple dose injections to advanced hybrid closed loop
ISPAD 2023 Pediatric diabetes in a rapidly changing world; Rotterdam, The Netherlands; October 18-21, 2023

7. Kyriaki Hatziagapiou, Ioannis- Anargyros Vasilakis, Maria Binou, Maria Dolianiti, Nicolas C. Nicolaides, Emmanouil Zoumakis, Chryssanthi Papathanasiou, Eleni Gkougkouli, Konstantina Barouti, Christina Kanaka-Gantenbein, Sophia D. Sakka
The awakening of the hypothalamic-pituitary-gonadal axis in the post-COVID era; the Greek experience.
ESPE 2023 – The 61st Annual Meeting of the European Society of Paediatric Endocrinology; Hague, Netherlands; September 21-23 2023.

8. Kyriaki Hatziagapiou, Amalia Sertedaki, Vasiliki Dermentzoglou, Christina Kanaka-Gantenbein, Sophia D. Sakka
Kenny Caffey syndrome 2; expanding the clinical spectrum
ESPE 2023 – The 61st Annual Meeting of the European Society of Paediatric Endocrinology; Hague, Netherlands; September 21-23 2023

9. Eleni Koniari, Kyriaki Hatziagapiou, Anastasia Skouma, Fotis Chaliotis, Panagiota Drosatou, Evelina Tsani, Vasiliki Blatsa, George Chrousos
Genetic evidence for a causal relationship between severe hyperlipidemia and Type 1 Diabetes
ESPE 2023 – The 61st Annual Meeting of the European Society of Paediatric Endocrinology; Hague, Netherlands; September 21-23 2023.

10. Kyriaki Hatziagapiou, Olti Nikola, Eleni Kakouri, George Lambrou, Konstantinos Bethanis, Elias Christoforides, Eleni Koniari, P. Tarantilis, Christina Kanaka- Gantenbein.
Integrating non-psychoactive phytocannabinoids and their cyclodextrin inclusion complexes into the treatment of pediatric cancers
53rd Congress of the international Society of Paediatric Oncology (SIOP) Virtual Congress; October 21-24, 2021

11. Kyriaki Hatziagapiou, Olti Nikola, Eleni Kakouri, George Lambrou, Eleni Koniari, Christina Kanaka- Gantenbein, P. Tarantilis.
Integrating saffron metabolomics into medulloblastoma treatment.
53rd Congress of the international Society of Paediatric Oncology (SIOP) Virtual Congress; October 21-24, 2021

12. Kyriaki Hatziagapiou, Olti Nikola, Eleni Kakouri, George
Lambrou, Eleni Koniari, Christina Kanaka-Gantenbein, Petros Tarantilis.
Integrating Saffron Metabolomics into the treatment of pediatric cancers.
10th Europaediatrics Congress; Zagreb, Croatia; 7–9 October 2021

13. Kyriaki Hatziagapiou, Konstantinos Bethanis, Olti Nikola, Elias
Christoforides, Eleni Koniari, Eleni Kakouri, George Lambrou, Christina Kanaka- Gantenbein.
Integrating non psychoactive phytocannabinoids and their, cyclodextrin inclusion complexes into the treatment of neuroblastoma 10th Europaediatrics Congress; Zagreb, Croatia; 7–9 October 2021

14. Kyriaki Hatziagapiou, Olti Nikola, Eleni Kakouri, George Lambrou, Christina Kanaka-Gantenbein, Petros Tarantilis.
Saffron metabolomics into glioblastoma treatment.
5th Minnesota Neuro-Oncology Virtual Symposium: Innovation of the Mind; Minneapolis, MN, USA, May 17-18th, 2021.

15. Kyriaki Hatziagapiou, Konstantinos Bethanis, Olti Nikola, Elias Christoforides, George Lambrou, Eleni Kakouri, Christina Kanaka-Gantenbein.
Cyclodextrin inclusion complexes of cannabidiol for the treatment of glioblastoma.
5th Minnesota Neuro-Oncology Virtual Symposium: Innovation of
the Mind; Minneapolis, MN, USA, May 17-18th, 2021.

16. Kyriaki Hatziagapiou, Konstantinos Bethanis, Olti Nikola, Elias Christoforides, Eleni Koniari, Eleni Kakouri, George Lambrou, Christina Kanaka-Gantenbein
Integrating Non-Psychoactive Phytocannabinoids and Their Cyclodextrin Inclusion Complexes into the Treatment of Glioblastoma
ICPNDDS001 2021: International Conference on Pharmaceutics and Novel Drug Delivery Systems; April 22-23, 2021, London, United Kingdom.

17. Eleni Kakouri, Kyriaki Hatziagapiou, Charalabos Kanakis, George Lambrou, Petros A. Tarantilis.
Crocins from Crocus sativus L.: a precious nutritional source as an agent against medulloblastoma human cell line.
4th Global Summit on Herbals & Traditional Medicine (Herbals Summit 2018); Osaka, Japan, October 3-4, 2018.

18. Kyriaki Hatziagapiou, Maria Braoudaki, Kostas Bethanis, Konstantina Yannakopoulou, Athanasios Anastasiou, Georgia Koutsouri, Dimitrios Koutsouris, George I. Lambrou. (2018)
Computational Analysis of Gefitinib and MethylatedHydroxypropylated Cyclodextrin Inclusion Complexes for the Treatment of Childhood Malignancies.
IEEE International Symposium on Biomedical Health Informatics, 4-7 March 2018, Las Vegas, Nevada, USA (IEEE BHI 2018).

19. Kyriaki Hatziagapiou, Eleni Kakouri, Konstantinos Bethanis, Alexandra Nikola, Eleni Koniari, Charalabos Kanakis, Elias Christoforides, George Lambrou, Petros Tarantilis.
Inhibitory Effects of Crocin from Crocus Sativus L. on Cell Proliferation of a Medulloblastoma Human Cell Line.
ICPOCP 2017: 19th International Conference on Pediatric Oncology and Clinical Pediatrics; December 14-15 2017, Barcelona, Spain.

20. Kiriaki Hatziagapiou, Eleftheria Kaiafa,Paraskevi Zosi, Dionisis Karakaidos, Soultana Georga, Thomais Vlahou, Likourgos Kanaris, Georgios Kafalidis.
Growth Hormone Treatment to final height in children with idiopathic short stature: Evidence for an early therapy initiation effect.
53rd Annual ESPE meeting; 18-20 September 2014, Dublin, Ireland.

21. Kyriaki Hatziagapiou, Maria Braoudaki, George I. Lambrou, Franzeska Tsorteki, Fotini Tzortzatou-Stathopoulou, Konstantinos Bethanis, Vasilki Gemou-Engesaeth.
Clinical Uses Of Gefitinib/Cyclodextrin Inclusion Complexes; Physicochemical Approaches And Potential Novel Cancer Therapeutic Interventions.
16th International Symposium On Pediatric Neuro-Oncology; 28 June-2 July 2014, Singapore.

22. Asimina Salapata, Kyriaki Hatziagapiou, Marditsa Psychogiou, Ioannis Kalliatsos, Euthimia Zaharia, Zlatka Nikitaki, Lykourgos Kanaris.
Unusual presentation of Lyme disease in a 13-year old boy in Greece.
5th Europaediatrics; 23-26 June 2011, Vienna, Austria.

23. Karakaidos D., Kafalidis G., Patsourou E., Zosi P., Salapata A., Hatziagapiou K., Karis Ch.
Cushing’s syndrome due to topical corticosteroids absorption.
49th Annual Meeting of ESPE (European Society for Paediatric Endocrinology); September 22-25, 2010, Prague, Czech Republic.

24. Kafalidis G., Zosi P., Salapata A., Hatziagapiou K., Zaharia T., Isaakidou Ε., Karis Ch.
Final height in Growth Hormone deficient children.
49th Annual Meeting of ESPE (European Society for Paediatric Endocrinology); September 22-25, 2010, Prague, Czech Republic.

ΠΕΡΙΛΗΨΕΙΣ ΣΕ ΠΡΑΚΤΙΚΑ ΕΛΛΗΝΙΚΩΝ ΣΥΝΕΔΡΙΩΝ ΜΕ ΚΡΙΤΕΣ (PEER-REVIEWED ABSTRACTS)-
ΔΗΜΟΣΙΕΥΣΗ ΣΕ ΠΡΑΚΤΙΚΑ ΕΛΛΗΝΙΚΩΝ ΣΥΝΕΔΡΙΩΝ (CONFERENCE ABSTRACT PROCEEDINGS)

1. Κ. Χατζηαγαπίου, Ε. Κόνιαρη, Γ.Π. Χρούσος
Ασθενής με ενωρίς έναρξης νοσογόνο παχυσαρκία: Γενετική προσέγγιση και θεραπευτικές προκλήσεις
2η Εκπαιδευτική Ημερίδα Παιδιατρικής και Εφηβικής Ενδοκρινολογίας, 15 Φεβρουαρίου 2025, Αθήνα.
Προφορική ομιλία

2. Κ. Χατζηαγαπίου, Σ. Δ. Σακκά, Νικόλας Νικολαΐδης, M. Δολιανίτη, Ι. Α. Βασιλάκης, Μαρία Μπίνου, Ιωάννα Φαράκλα, Ελένη Αγγελοπούλου, Μιχαέλα Νικολάου, Χ. Παπαθανασίου, Χ. Κανακά-Gantenbein.
Μελετώντας την ενεργοποίηση του άξονα υποθαλάμου -υπόφυσης- γονάδων στην περίοδο του SARS-COV-2.
9ο Συνέδριο Παιδιατρικής και Εφηβικής Γυναικολογίας, 25-26 Μαΐου 2024, Αθήνα.
Ανηρτημένη ανακοίνωση

3. Μιχαέλα Νικολάου, Δανάη Γεωργακοπούλου, Ιωάννης-Ανάργυρος Βασιλάκης, Μαρία Μπίνου, Άννυ Μερτζανιάν, Μαρία Δολιανίτη, Ιωάννα Φαράκλα, Σοφία Σακκά, Ελένη Αγγελοπούλου, Κυριακή Χατζηαγαπίου, Νικόλας Νικολαΐδης, Αμαλία Σερτεδάκη, Χριστίνα Κανακά Gantenbein.
Συγγενής υπερινσουλινισμός στην παιδική και εφηβική ηλικία. Η εμπειρία ενός κέντρου τα τελευταία 16 χρόνια.
9ο Συνέδριο Παιδιατρικής και Εφηβικής Γυναικολογίας, 25-26 Μαΐου 2024, Αθήνα.
Ανηρτημένη ανακοίνωση

4. Συχνότητα πρωτοδιάγνωσης Σακχαρώδους Διαβήτη τύπου 1 και βαρύτητας διαβητικής κετοξέωσης κατά την 4ετια πριν και την 4ετια μετά την έναρξη της πανδημίας Covid-19
Μπαρλαμπά Δ., Τσιγκρή Α., Φαράκλα Ι., Χατζηαγαπίου Κ., Γεωργακοπούλου Δ., Γκίκα Ι., Κώτση E., Αγγελοπούλου Ε., Νικολάου Μ., Σακκά Σ., Νικολαΐδης Ν., Μπίνου Μ., Δολιανίτη Μ., Βασιλάκης Ι.Α., Κανακά-Gantenbein Χ.
51ο Πανελλήνιο Συνέδριο Ενδοκρινολογίας, Μεταβολισμού & Σακχαρώδη Διαβήτη, 10-13 Απριλίου 2024, Αθήνα
Προφορική ανακοίνωση

5. Ιωάννης-Ανάργυρος Βασιλάκης, Δανάη Γεωργακοπούλου, Κυριακή Χατζηαγαπίου, Σοφία Σακκά, Μαρία Μπίνου, Μαρία Δολιανίτη, Ιωάννα Φαράκλα, Μιχαέλα Νικολάου, Ελένη Αγγελοπούλου, Νικόλας Χρ. Νικολαΐδης, Χριστίνα Κανακά-Gantenbein
Γρήγορη βελτίωση της γλυκαιμικής ρύθμισης παιδιών με Σακχαρώδη Διαβήτη Τύπου 1 που μετέβησαν απο το σχήμα πολλαπλών ενέσεων με συνεχή καταγραφή γλυκόζης, στο υβριδικό κλειστό κύκλωμα ινσουλινοθεραπείας (AHCL), που διατηρείται μέχρι τους 12 μήνες χρήσης
22ο Πανελλήνιο Διαβητολογικό Συνέδριο, 27-30 Μαρτίου 2024, Αθήνα
Προφορική ανακοίνωση

6. Ιωάννης-Ανάργυρος Βασιλάκης, Δανάη Μπαρλαμπά, Κυριακή Χατζηαγαπίου, Ελένη Αγγελοπούλου, Ιωάννα Γκίκα, Έλενα Κώτση, Σοφία Σακκά, Μαρία Μπίνου, Μαρία Δολιανίτη, Ιωάννα Φαράκλα, Μιχαέλα Νικολάου, Αλεξάνδρα Τσιγκρή, Νικόλας Χρ. Νικολαΐδης, Χριστίνα Κανακά-Gantenbein
Χρήση πενών ινσουλίνης με καταγραφή δεδομένων γλυκόζης και ινσουλίνης χωρίς δεδομένα ενεργούς ινσουλίνης (tracking insulin pen – tip) σε παιδιατρικό πληθυσμό – μονοκεντρική μελέτη
22ο Πανελλήνιο Διαβητολογικό Συνέδριο, 27-30 Μαρτίου 2024, Αθήνα
Ανηρτημένη ανακοίνωση

7. Ελένη Κόνιαρη, Κυριακή Χατζηαγαπίου, Κωνσταντίνα Γεωργούλια, Σοφία Ζουγανέλη, Βασιλική Σίδερη, Ελένη Καψαμπέλη, Ελευθερία Χαιρέτη, Αχιλλέας Αττιλάκος, Γεώργιος Π. Χρούσος
Περιστατικό Ομόζυγης Αβηταλιποπρωτεϊναιμίας σε Βρέφος
8ο Συνέδριο Παιδιατρικής και Εφηβικής Γυναικολογίας, 27-28 Μαΐου 2023, Αθήνα
Ανηρτημένη ανακοίνωση

8. Σοφία Μαυρίκου, Βασίλειος Τσεκούρας, Κυριακή Χατζηαγαπίου, Φωτεινή Παραδείση , Πέτρος Μπακάκος , Αθανάσιος Μίχος, Αντωνία Κουτσούκου, Ελένη Κόνιαρη, Όλτι Νικόλα, Ιωσήφ Παπαπαρασκευάς, Χριστίνα Κανακά-Gantenbein, Σπυρίδων Κίντζιος
Παρουσίαση καινοτόμου κυτταρικού βιο-ηλεκτρικού βιοαισθητήρα για την ταχεία ανίχνευση της πρωτεΐνης ακίδας S1 του ιού SARS-CoV-2 σε κλινικά δείγματα.
19ο Πανελλήνιο Συνέδριο Κλινικής Χημείας, 4-6 Νοεμβρίου 2021, Αθήνα
Aνηρτημένη ανακοίνωση

9. Σοφία Μαυρίκου, Βασίλειος Τσεκούρας, Κυριακή Χατζηαγαπίου, Φωτεινή Παραδείση , Πέτρος Μπακάκος , Αθανάσιος Μίχος, Αντωνία Κουτσούκου, Όλτι Νικόλα, Ελένη Κόνιαρη, Ιωσήφ Παπαπαρασκευάς, Χριστίνα Κανακά-Gantenbein, Σπυρίδων Κίντζιος.
Εφαρμογή κυτταρικού βιο- ηλεκτρικού βιοαισθητήρα σε κλινικά δείγματα για την ταχεία ανίχνευση της πρωτεΐνης ακίδας S1 του ιού SARS-CοV-2.
59ο Πανελλήνιο Παιδιατρικό Συνέδριο, 15-17 Οκτωβρίου 2021, Αθήνα
Προφορική ανακοίνωση

10. Ελένη Κακούρη, Κυριακή Χατζηαγαπίου, Όλτι Νικόλα, Χαράλαμπος Κανάκης, Γιώργος Λάμπρου, Χριστίνα Κανακά-Gantenbein, Παναγιώτης Τρίγκας, Πέτρος Α. Ταραντίλης.
Φυσικά προϊόντα στην αντιμετώπιση εγκεφαλικών όγκων
59ο Πανελλήνιο Παιδιατρικό Συνέδριο, 15-17 Οκτωβρίου 2021, Αθήνα
Ανηρτημένη ανακοίνωση

11. Κυριακή Χατζηαγαπίου, Όλτι Νικόλα, Ελένη Κακούρη, Ελένη Κόνιαρη, Κωνσταντίνα Γεωργούλια, Γιώργος Λάμπρου, Χριστίνα Κανακά-Gantenbein, Πέτρος Ταραντίλης
Η χρήση βιοδραστικών ουσιών του Saffron (Crocus Sativus L.) για την αντιμετώπιση του μυελοβλαστώματος.
59ο Πανελλήνιο Παιδιατρικό Συνέδριο, 15-17 Οκτωβρίου 2021, Αθήνα
Ανηρτημένη ανακοίνωση

12. Κυριακή Χατζηαγαπίου, Όλτι Νικόλα, Πέτρος Ταραντίλης, Ελένη Κακούρη, Γιώργος Λάμπρου, Χριστίνα Κανακά-Gantenbein
Μελέτη βιοδραστικών συστατικών του saffron για την αντιμετώπιση του μυελοβλαστώματος
46ο Ετήσιο Πανελλήνιο Ιατρικό Συνέδριο, 17-20 Ιουνίου 2020, Αθήνα.
Προφορική ανακοίνωση

13. Κυριακή Χατζηαγαπίου, Κωνσταντίνος Μπεθάνης, Όλτι Νικόλα, Ηλίας Χριστοφορίδης, Γιώργος Λάμπρου, Χριστίνα Κανακά-Gantenbein
Μελέτη μη ψυχοτρόπων φυτοκανναβινοειδών και προϊόντων εγκλεισμού τους σε κυκλοδεξτρίνες ως πιθανές καινοτόμες θεραπείες για το μυελοβλάστωμα.
46ο Ετήσιο Πανελλήνιο Ιατρικό Συνέδριο, 17-20 Ιουνίου 2020, Αθήνα.
Προφορική ομιλία

14. Hatziagapiou Kyriaki, Kakouri Eleni, Bethanis Konstantinos, Koniari Eleni, Kanakis Charalampos, Lambrou George, Tarantilis Petros.
Crocin from Crocus Sativus L. Exerts Significant Cytotoxicity on a Medulloblastoma Human Cell Line.
27th Meeting of the Hellenic Society for Neuroscience; 8th-10th December 2017, Athens, Greece.
Ανηρτημένη ανακοίνωση

15. Κ. Χατζηαγαπίου, Μ. Μπραουδάκη, Γ. Λάμπρου, Κ. Μπεθάνης, Κ.Γιαννακοπούλου, Μ. Καρπούζας, Φ. Τσορτέκη, Η. Χριστοφορίδης, Ν.Καβαντζάς, Β. Μηλιώνης, Φ. Τζωρτζάτου-Σταθοπούλου, Β. Γέμου–Engesaeth.
Μια καινοτόμος και στοχευμένη θεραπευτική προσέγγιση στο νευροβλάστωμα: Σύμπλοκα μικροεγκλεισμού γεφιτινίμπης-κυκλοδεξτρινών.
16ο Ετήσιο Παιδονευρολογικό Συνέδριο, 9-10 Δεκεμβρίου 2016, Αθήνα.
Ανηρτημένη ανακοίνωση

16. Κυριακή Χατζηαγαπίου, Βασιλική Ζούβελου, Γεώργιος Καφαλίδης Διονύσιος Καρακαϊδός, Μαρία Κωνσταντοπούλου, Ελένη Γαλανοπούλου, Θωμαΐς Βλάχου.
Προσέλευση στο Παιδιατρικό Τμήμα Επειγόντων ενός Γενικού Νοσοκομείου. Αναδρομική Μελέτη δύο ετών 2012-2013.
52ο Πανελλήνιο Παιδιατρικό Συνέδριο, 6-8 Ιουνίου 2014, Ρόδος.
Ανηρτημένη ανακοίνωση

17. Σουλτάνα Γεωργά, Αιμίλιος Μιχαηλίδης, Ελευθερία Καϊάφα, Ελένη Καναβούρα, Αθηνά Πέτρου, Κυριακή Χατζηαγαπίου, Λυκούργος Κανάρης.
Φυματιοαντίδραση και Εμβολιασμός Με BCG στους μαθητές της Α’ Δημοτικού των σχολείων Δήμου της Δυτικής Αττικής.
52ο Πανελλήνιο Παιδιατρικό Συνέδριο, 6-8 Ιουνίου 2014, Ρόδος.
Ανηρτημένη ανακοίνωση

18. Ελευθερία Καϊάφα, Κυριακή Χατζηαγαπίου, Γεώργιος Καφαλίδης Παρασκευή Ζώση, Διονύσιος Καρακαϊδός, Θεοδώρα Ξενοπούλου, Λυκούργος Κανάρης.
Αποτελεσματικότητα θεραπείας με χαμηλές δόσεις rGH στα παιδιά με ιδιοπαθή ανεπάρκεια Αυξητικής Ορμόνης.
52ο Πανελλήνιο Παιδιατρικό Συνέδριο, 6-8 Ιουνίου 2014, Ρόδος.
Ανηρτημένη ανακοίνωση

19. Κ. Χατζηαγαπίου, Μ. Μπραουδάκη,, Γ. Λάμπρου, Φ. Τσορτέκη, Φ. Τζωρτζάτου-Σταθοπούλου Κ. Μπεθάνης, Β. Γέμου-Engesaeth.
Μελέτη της Επίδρασης Αναστολέων Τυροσινικής Κινάσης σε Νευροβλαστώματα.
40ο Ετήσιο Πανελλήνιο Ιατρικό Συνέδριο, 14-17 Μαΐου 2014, Αθήνα.
Προφορική ανακοίνωση

20. Π. Τριανταφυλλίδη, K. Χατζηαγαπίου, Ρ. Σώκου, Α. Κωνσταντινίδη, Ξ. Αγρογιάννη, Κ. Σκορδίλη, Ι. Λαμπαδαρίδης.
“Ghost Baby” Kαλή έκβαση νεογνού με βαριά Εμβρυομητρική Μετάγγιση.
5ο Συνέδριο Νεογνολογίας, 10-11 Μαΐου 2014, Αθήνα.
Ανηρτημένη ανακοίνωση

21. Κ. Χατζηαγαπίου, Μ. Μπραουδάκη,, Γ. Λάμπρου, Φ. Τσορτέκη, Φ. Τζωρτζάτου-Σταθοπούλου Κ. Μπεθάνης, Β. Γέμου-Engesaeth.
Μελέτη της επίδρασης του Gefitinib απουσία και παρουσία κυκλοδεξτρινών σε κυτταρικές σειρές όγκων του νευρικού συστήματος.
3ο Πανελλήνιο Συνέδριο Παιδιατρικής Αιματολογίας-Ογκολογίας, 21 & 22 Φεβρουαρίου 2014, Αθήνα.
Ανηρτημένη ανακοίνωση
22. Ασημίνα Σαλαπάτα, Κυριακή Χατζηαγαπίου, Μαρδίτσα Ψυχογιού, Ιωάννης Καλλιάτσος, Ευθυμία Ζαχαριά, Ζλάτκα Νικητάκη, Λυκούργος Κανάρης.
Νόσος Lyme με ασυνήθεις εκδηλώσεις σε αγόρι ηλικίας 13 ετών.
49ο Πανελλήνιο Παιδιατρικό Συνέδριο, 10-12 Ιουνίου 2011, Μεσσηνία. Ανηρτημένη ανακοίνωση

23. Καφαλίδης Γ., Καρακαϊδός Δ., Σαλαπάτα Α., Πατσούρου Ε., Χατζηαγαπίου Κ., Ισαακίδου Ε., Καρής Χ.
Η συμμετοχή των εργαζομένων σε μεγάλο Νοσοκομείο στον εμβολιασμό έναντι του ιού της Γρίπης Η1Ν1.
36o Πανελλήνιο Ιατρικό Συνέδριο, Αθήνα, 4- 8 Μαΐου 2010.
Ανηρτημένη ανακοίνωση

24. Χατζηαγαπίου Κ., Μπραουδάκη Μ., Λάμπρου Γ., Παπαθανασίου Χ. Καρπούζας Μ., Τζωρτζάτου-Σταθοπούλου.
Μελέτη των Αναστολέων του Υποδοχέα του Επιδερμικού Αυξητικού Παράγοντα (ΕGFR) για την αντιμετώπιση Όγκων του ΚΝΣ σε παιδιά.
10ο Πανελλήνιο Παιδονευρολογικό Συνέδριο, 10-11 Δεκεμβρίου 2010, Αθήνα.
Ανηρτημένη ανακοίνωση

25. Ευφροσύνη Πατσούρου, Κυριακή Χατζηαγαπίου, Ελένη Σολδάτου, Χρήστος Τρομπούκης, Χαράλαμπος Μιχαλόπουλος, Φοίβος Προδρόμου, Χρήστος Καρής.
Μυελοβλάστωμα παιδικής ηλικίας με ασυνήθιστη κλινική προσβολή.
10ο Πανελλήνιο Παιδονευρολογικό Συνέδριο, 10-11 Δεκεμβρίου 2010, Αθήνα. Ανηρτημένη ανακοίνωση

ΟΜΙΛΙΕΣ ΣΕ ΣΥΝΈΔΡΙΑ-ΗΜΕΡΙΔΕΣ

1. Δωρεά Οργάνων και Μεταμοσχεύσεις
35ο Συνέδριο Παγκρήτιας Παιδιατρικής Εταιρείας,
20-22 Οκτωβρίου 2023, Χανιά

2. Ενδιαφέροντα περιστατικά -Σύνδρομο ROHHAD
8ο Μετεκπαιδευτικό Σεμινάριο στη θεραπευτική αντιμετώπιση του σακχαρώδους διαβήτη στα παιδιά και τους εφήβους
Η σύγχρονη τεχνολογία στην αντιμετώπιση του Σακχαρώδη Διαβήτη τύπου 1
3 Φεβρουαρίου 2024, Αθήνα

3. Ενδιαφέροντα περιστατικά διαταραχών της αύξησης και παθήσεων υποθαλάμου/υπόφυσης-Σύνδρομο ROHHAD
Ημερίδας Παιδικής και Εφηβικής Ενδοκρινολογίας
10 Φεβρουαρίου 2024, Αθήνα

4. Συμπλήρωση φύλλου δότη και έντυπα ΕΟΜ
Εκπαιδευτικό Σεµινάριο του ΕΟΜ για Τοπικούς Συντονιστές Μεταμοσχεύσεων και Επαγγελµατίες Υγείας, Καινοτομίες & Βέλτιστες Πρακτικές
30 Σεπτεμβρίου έως 2 Οκτωβρίου 2024, Αθήνα

5. Πού οφείλεται η παχυσαρκία στα παιδιά;
Συνέδριο για την Αντιμετώπιση της Επιδημίας της Παχυσαρκίας – Συμμαχία για την Καταπολέμηση της Παχυσαρκίας (Action4Obesity)
21-23 Οκτωβρίου 2024, Αθήνα

6. Δωρεά Οργάνων
2ο Στρογγυλό Τραπέζι «Μεταμοσχεύσεις-∆ωρεά οργάνων-Ευαισθητοποίηση»
5η Νοσηλευτικής Ημερίδα “ Οι Νοσηλευτές: θεματοφύλακες για τη διασφάλιση της ποιότητας στο χώρο της υγείας”
31 Οκτωβρίου 2024, ΓΝ Νίκαιας -Πειραιά «Άγιος Παντελεήμων»

ΣΥΓΓΡΑΦΙΚΟ ΕΡΓΟ – ΕΠΙΜΕΛΕΙΑ & ΚΕΦΑΛΑΙΑ ΣΕ ΒΙΒΛΙΑ

1. Παιδιατρική Αιματολογία/Ογκολογία (2020)
Φωτεινή Τζωρτζάτου-Σταθοπούλου με τη συμμετοχή μελών των ιατρικών κλινικών της Ελλάδας
Εκδόσεις Π.Χ. Πασχαλίδης και Broken Hill Publishers LTD
(ISBN 9789925575251)
Κεφάλαιο 55 Απώτερες επιδράσεις της θεραπείας του καρκίνου
Χατζηαγαπίου Κυριακή, Φωτεινή Τζωρτζάτου-Σταθοπούλου σελ 1163-1233

2. Acute Lymphoblastic Leukemia: Etiology, Pathogenesis and Treatments. S. Vecchione & L. Tedesco (Eds.), Hauppauge, New York: Nova Science Publishers, Inc, c2011 (ISBN 978-1614708728) (2011)
i. Hatziagapiou K, Braoudaki M, Katsibardi K, Lambrou GI, Tzortzatou-Stathopoulou F.
Genome wide association studies in pediatric acute lymphoblastic leukemia: pathogenesis and therapy; pp. 1-52.
ii. Lambrou GI, Braoudaki M, Hatziagapiou K, Katsibardi K, Tzortzatou-Stathopoulou F.
Systems approaches in childhood leukemogenesis; pp. 119-134.
iii. Katsibardi K, Braoudaki M, Lambrou GI, Hatziagapiou K, Tzortzatou-Stathopoulou F.
Minimal residulal disease monitoring in childhood acute lymphoblastic leukemia; pp. 169-18.
iv. Braoudaki M, Katsibardi K, Lambrou GI, Hatziagapiou K, Tzortzatou-Stathopoulou F.
Clinical relevance and application of cytogenetic approaches in pediatric acute lymphoblastic leukaemia; pp. 183-196.

3. Δερματικός Ερυθηματώδης Λύκος:. Κλινικές Μορφές, Παθογένεια, Εργαστηριακή Διάγνωση, Θεραπεία (2011)
Αυγερινού Γεωργία, Σταυρόπουλος Παναγιώτης, Κατσάμπας Ανδρέας
Εκδόσεις Καυκάς ‘’Kafkas Publications’’
Συγγραφή Κεφαλαίου: « Παθογένεση Δερματικού Ερυθηματώδους Λύκου» (σελ. 39-107) και συνολική επιμέλεια της έκδοσης.

ΟΡΓΑΝΩΤΙΚΗ ΕΠΙΤΡΟΠΗ ΣΥΝΕΔΡΙΩΝ

Οργανωτική Επιτροπή στο 3ο Συμπόσιο στην Κλινική Γενετική & στη Γονιδιωματική & 19ο Εκπαιδευτικό Σεμινάριο στη Γενετική.
Ελληνική Εταιρεία Ιατρικής Γενετικής
31 Μαΐου & 1η Ιουνίου 2019
Αίγλη Ζαππείου, Αθήνα

ΒΡΑΒΕΥΣΗ ΣΕ ΣΥΝΕΔΡΙΟ

1. Βραβείο Ι. Αλιβιζάτου στην καλύτερη εργασία για το Σακχαρώδη Διαβήτη
Συχνότητα πρωτοδιάγνωσης Σακχαρώδους Διαβήτη τύπου 1 και βαρύτητας διαβητικής κετοξέωσης κατά την 4ετια πριν και την 4ετια μετά την έναρξη της πανδημίας Covid-19
Μπαρλαμπά Δ., Τσιγκρή Α., Φαράκλα Ι., Χατζηαγαπίου Κ., Γεωργακοπούλου Δ., Γκίκα Ι., Κώτση E., Αγγελοπούλου Ε., Νικολάου Μ., Σακκά Σ., Νικολαΐδης Ν., Μπίνου Μ., Δολιανίτη Μ., Βασιλάκης Ι.Α., Κανακά-Gantenbein Χ.
51ο Πανελλήνιο Συνέδριο Ενδοκρινολογίας, Μεταβολισμού & Σακχαρώδη Διαβήτη, 10-13 Απριλίου 2024, Αθήνα

2. 2ο Βραβείο στο διαγωνισμό καινοτομίας 2021 IDea Incubator -Johnson & Johnson Innovation JLABS του IDSA (Infectious Diseases South America) Foundation
‘Cell-Based Bio-Electric Biosensor for the Detection of the SARS-CoV-2 S1 Spike Protein Antigen Team’

3. 3Ο Βραβείο Διάκρισης στο Χειρισμό Περιστατικού
Virtual Allergy Masterclass, Κολλέγιο Αλλεργιολογίας Παίδων
28 Νοεμβρίου 2020, Αθήνα

ΣΥΣΤΑΤΙΚΕΣ ΕΠΙΣΤΟΛΕΣ

1. Oμότιμος Καθηγητής Παιδιατρικής-Παιδιατρικής Ενδοκρινολογίας Γ.Π. Χρούσος
2. Καθηγητής και Πρύτανης Γεωπονικού Πανεπιστημίου Αθηνών
Σ. Κίντζιος
3. Καθηγητής Ενόργανης Χημικής Ανάλυσης Φυσικών Προϊόντων
Κοσμήτορας της Σχολής Επιστημών Τροφίμων και Διατροφής, Γεωπονικού Πανεπιστημίου Αθηνών
Π. Ταραντίλης
4. Επίκουρη Καθηγήτρια Μοριακής Γενετικής Μ. Μπραουδάκη
University of Hertfordshire, Hatfield, Hertfordshire, UK

ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΔΙΕΘΝΗ ΠΕΡΙΟΔΙΚΑ

Free androgen index as a predictor of blood pressure progression and accelerated vascular aging in menopause.

Georgiopoulos GA, Lambrinoudaki I, Athanasouli F, Armeni E, Rizos D, Kazani M, Karamanou M, Manios E, Augoulea A, Stellos K, Papamichael C, Stamatelopoulos K.

Atherosclerosis. 2016 Feb 20;247:177-183. doi: 10.1016/j.atherosclerosis.2016.02.021. [Epub ahead of print]

 

EMAS recommendations for conditions in the workplace for menopausal women.

Griffiths A, Ceausu I, Depypere H, Lambrinoudaki I, Mueck A, Pérez-López FR, van der Schouw YT, Senturk LM, Simoncini T, Stevenson JC, Stute P, Rees M.

Maturitas. 2016 Mar;85:79-81. doi: 10.1016/j.maturitas.2015.12.005. Epub 2015 Dec 15.

 

 

Preliminary evidence for gender effects of levetiracetam monotherapy duration on bone health of patients with epilepsy.

Artemiadis AK, Lambrinoudaki I, Voskou P, Tsivgoulis G, Safouris A, Bougea A, Giannopoulos S, Gatzonis S, Triantafyllou N.

Epilepsy Behav. 2016 Feb;55:84-6. doi: 10.1016/j.yebeh.2015.12.025. Epub 2016 Jan 13.

 

EMAS position statement: Testosterone replacement therapy in the aging male‏.

Dimopoulou C, Ceausu I, Depypere H, Lambrinoudaki I, Mueck A, Pérez-López FR, Rees M, van der Schouw YT, Senturk LM, Simonsini T, Stevenson JC, Stute P, Goulis DG.

Maturitas. 2016 Feb;84:94-9. doi: 10.1016/j.maturitas.2015.11.003. Epub 2015 Nov 10.

 

Association of sex hormones and glucose metabolism with the severity of multiple sclerosis.

Triantafyllou N, Thoda P, Armeni E, Rizos D, Kaparos G, Augoulea A, Alexandrou A, Creatsa M, Tsivgoulis G, Artemiades A, Panoulis C, Lambrinoudaki I.

Int J Neurosci. 2015 Sep 25:1-8. [Epub ahead of print]

 

Stress urinary incontinence and endogenous sex steroids in postmenopausal women.

Augoulea A, Sioutis D, Rizos D, Panoulis C, Triantafyllou N, Armeni E, Deligeoroglou E, Chrelias C, Creatsa M, Liapis A, Lambrinoudaki I.

Neurourol Urodyn. 2015 Sep 18. doi: 10.1002/nau.22885. [Epub ahead of print]

 

Non-hormonal management of menopausal vasomotor symptoms: Psychosocial interventions.

Mintziori G, Goulis DG, Lambrinoudaki I, Ceausu I, Depypere H, Erel CT, Pérez-López FR, Schenck-Gustafsson K, Simoncini T, Tremollieres F, Rees M.

Maturitas. 2015 Dec;82(4):444-5. doi: 10.1016/j.maturitas.2015.08.011. Epub 2015 Sep 5. No abstract available.

 

Maternal serum osteocalcin at 11-14 weeks of gestation in gestational diabetes mellitus.

Papastefanou I, Eleftheriades M, Kappou D, Lambrinoudaki I, Lavranos D, Pervanidou P, Sotiriadis A, Hassiakos D, Chrousos GP.

Eur J Clin Invest. 2015 Oct;45(10):1025-31. doi: 10.1111/eci.12500. Epub 2015 Aug 24.

 

A case of postmenopausal androgen excess.

Lambrinoudaki I, Dafnios N, Kondi-Pafiti A, Triantafyllou N, Karopoulou E, Papageorgiou A, Augoulea A, Armeni E, Creatsa M, Vlahos N.

Gynecol Endocrinol. 2015 Oct;31(10):760-4. doi: 10.3109/09513590.2015.1075500. Epub 2015 Aug 18.

 

Indices of adiposity and thyroid hormones in euthyroid postmenopausal women.

Lambrinoudaki I, Armeni E, Rizos D, Georgiopoulos G, Athanasouli F, Triantafyllou N, Panoulis K, Augoulea A, Creatsa M, Alexandrou A, Alevizaki M, Stamatelopoulos K.

Eur J Endocrinol. 2015 Aug;173(2):237-45. doi: 10.1530/EJE-15-0141.

 

Expression of gonadal steroid receptors in the ovaries of post-menopausal women with malignant or benign endometrial pathology: a pilot study.

Panoulis K, Christantoni E, Pliatsika P, Anagnostis P, Goulis DG, Kondi-Pafiti A, Armeni E, Augoulea A, Triantafyllou N, Creatsa M, Lambrinoudaki I.

Gynecol Endocrinol. 2015;31(8):613-7. doi: 10.3109/09513590.2015.1021324. Epub 2015 Jun 2.

 

Menopausal hormone therapy for the prevention of cardiovascular disease: Evidence-based customization.

Goulis DG, Lambrinoudaki I.

Maturitas. 2015 Aug;81(4):421-2. doi: 10.1016/j.maturitas.2015.05.001. Epub 2015 May 7. No abstract available.

 

EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms.

Mintziori G, Lambrinoudaki I, Goulis DG, Ceausu I, Depypere H, Erel CT, Pérez-López FR, Schenck-Gustafsson K, Simoncini T, Tremollieres F, Rees M.

Maturitas. 2015 Jul;81(3):410-3. doi: 10.1016/j.maturitas.2015.04.009. Epub 2015 Apr 22.

 

Determinants of Secondary Hyperparathyroidism in Bariatric Patients after Roux-en-Y Gastric Bypass or Sleeve Gastrectomy: A Pilot Study.

Alexandrou A, Tsoka E, Armeni E, Rizos D, Diamantis T, Augoulea A, Panoulis C, Liakakos T,Lambrinoudaki I.

Int J Endocrinol. 2015;2015:984935. doi: 10.1155/2015/984935. Epub 2015 Apr 9.

 

Connected health and integrated care: Toward new models for chronic disease management.

Chouvarda IG, Goulis DG, Lambrinoudaki I, Maglaveras N.

Maturitas. 2015 Sep;82(1):22-7. doi: 10.1016/j.maturitas.2015.03.015. Epub 2015 Mar 28. Review.

 

Sarcopenia in post-menopausal women: Is there any role for vitamin D?

Anagnostis P, Dimopoulou C, Karras S, Lambrinoudaki I, Goulis DG.

Maturitas. 2015 Sep;82(1):56-64. doi: 10.1016/j.maturitas.2015.03.014. Epub 2015 Mar 27. Review.

 

Vasomotor and depression symptoms may be associated with different sleep disturbance patterns in postmenopausal women.

Vousoura E, Spyropoulou AC, Koundi KL, Tzavara C, Verdeli H, Paparrigopoulos T, Augoulea A,Lambrinoudaki I, Zervas IM.

Menopause. 2015 Oct;22(10):1053-7. doi: 10.1097/GME.0000000000000442.

 

EMAS position statement: The ten point guide to the integral management of menopausal health.

Neves-E-Castro M, Birkhauser M, Samsioe G, Lambrinoudaki I, Palacios S, Borrego RS, Llaneza P, Ceausu I, Depypere H, Erel CT, Pérez-López FR, Schenck-Gustafsson K, van der Schouw YT, Simoncini T, Tremollieres F, Rees M.

Maturitas. 2015 May;81(1):88-92. doi: 10.1016/j.maturitas.2015.02.003. Epub 2015 Feb 11.

 

Increased Maternal Serum Interleukin-6 Concentrations at 11 to 14 Weeks of Gestation in Low Risk Pregnancies Complicated with Gestational Diabetes Mellitus: Development of a Prediction Model.

Hassiakos D, Eleftheriades M, Papastefanou I, Lambrinoudaki I, Kappou D, Lavranos D, Akalestos A, Aravantinos L, Pervanidou P, Chrousos G.

Horm Metab Res. 2016 Jan;48(1):35-41. doi: 10.1055/s-0034-1395659. Epub 2015 Jan 7.

 

Circulating androgens are associated with mood disturbances in young postmenopausal women.

Lambrinoudaki I, Bouziou G, Armeni E, Spyropoulou A, Koundi K, Rizos D, Augoulea A, Alexandrou A, Creatsa M, Panoulis C, Dendrinos S, Leonadrou AA, Zervas IM.

Climacteric. 2015 Apr;18(2):205-13. doi: 10.3109/13697137.2014.984674. Epub 2015 Jan 7.

 

EMAS position statement: individualized breast cancer screening versus population-based mammography screening programmes.

Depypere H, Desreux J, Pérez-López FR, Ceausu I, Erel CT, Lambrinoudaki I, Schenck-Gustafsson K, van der Schouw YT, Simoncini T, Tremollieres F, Rees M.

Maturitas. 2014 Dec;79(4):481-6. doi: 10.1016/j.maturitas.2014.09.002. Epub 2014 Sep 16.

 

Bsm1 vitamin D receptor polymorphism and calcium homeostasis following bariatric surgery.

Alexandrou A, Armeni E, Kaparos G, Rizos D, Tsoka E, Deligeoroglou E, Creatsa M, Augoulea A, Diamantis T, Lambrinoudaki I.

J Invest Surg. 2015 Feb;28(1):8-17. doi: 10.3109/08941939.2014.943857. Epub 2014 Sep 2.

 

Elevated placental growth factor concentrations at 11-14 weeks of gestation to predict gestational diabetes mellitus.

Eleftheriades M, Papastefanou I, Lambrinoudaki I, Kappou D, Lavranos D, Akalestos A, Souka AP, Pervanidou P, Hassiakos D, Chrousos GP.

Metabolism. 2014 Nov;63(11):1419-25. doi: 10.1016/j.metabol.2014.07.016. Epub 2014 Aug 5.

 

Vertebral fracture prevalence among Greek healthy middle-aged postmenopausal women: association with demographics, anthropometric parameters, and bone mineral density.

Lambrinoudaki I, Flokatoula M, Armeni E, Pliatsika P, Augoulea A, Antoniou A, Alexandrou A, Creatsa M, Panoulis C, Dendrinos S, Papacharalambous X.

Spine J. 2015 Jan 1;15(1):86-94. doi: 10.1016/j.spinee.2014.07.021. Epub 2014 Aug 12.

 

Variations in glomerular filtration rate are associated with subclinical atherosclerosis in healthy postmenopausal women.

Lambrinoudaki I, Tourlakis D, Armeni E, Kaparos G, Rizos D, Augoulea A, Alexandrou A, Kreatsa M, Deligeoroglou E, Stamatelopoulos K.

Menopause. 2015 Mar;22(3):317-24. doi: 10.1097/GME.0000000000000302.

 

EMAS position statement: management of uterine fibroids.

Pérez-López FR, Ornat L, Ceausu I, Depypere H, Erel CT, Lambrinoudaki I, Schenck-Gustafsson K, Simoncini T, Tremollieres F, Rees M.

Maturitas. 2014 Sep;79(1):106-16. doi: 10.1016/j.maturitas.2014.06.002. Epub 2014 Jun 9.

 

The effect of hormone therapy on biochemical and ultrasound parameters associated with atherosclerosis in 46,XY DSD individuals with female phenotype.

Tsimaris P, Deligeoroglou E, Athanasopoulos N, Economou E, Stamatelopoulos K, Rizos D, Papamichael C, Lambrinoudaki I, Mastorakos G, Creatsas G.

Gynecol Endocrinol. 2014 Oct;30(10):721-5. doi: 10.3109/09513590.2014.925868. Epub 2014 Jun 9.

 

Small medullary thyroid carcinoma: post-operative calcitonin rather than tumour size predicts disease persistence and progression.

Saltiki K, Rentziou G, Stamatelopoulos K, Georgiopoulos G, Stavrianos C, Lambrinoudaki E, Alevizaki M.

Eur J Endocrinol. 2014 Jul;171(1):117-26. doi: 10.1530/EJE-14-0076. Epub 2014 Apr 23.

 

EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture.

Triantafyllopoulos IK, Lambropoulou-Adamidou K, Nacopoulos CC, Papaioannou NA, Ceausu I, Depypere H, Erel CT, Pérez-López FR, Schenck-Gustafsson K, van der Schouw YT, Simoncini T, Tremollieres F, Rees M, Lambrinoudaki I; European Menopause and Andropause Society.

Maturitas. 2014 Jun;78(2):131-7. doi: 10.1016/j.maturitas.2014.03.002. Epub 2014 Mar 7. Review.

 

EMAS position statement: Menopause for medical students.

Brockie J, Lambrinoudaki I, Ceausu I, Depypere H, Erel CT, Pérez-López FR, Schenck-Gustafsson K, van der Schouw YT, Simoncini T, Tremollieres F, Rees M; European Menopause and Andropause Society.

Maturitas. 2014 May;78(1):67-9. doi: 10.1016/j.maturitas.2014.02.007. Epub 2014 Feb 19. No abstract available.

 

Psychological but not vasomotor symptoms are associated with temperament and character traits.

Kokras N, Papadopoulos L, Zervas IM, Spyropoulou A, Stamatelopoulos K, Rizos D, Creatsa M, Augoulea A, Papadimitriou GN, Lambrinoudaki I.

Climacteric. 2014 Aug;17(4):500-9. doi: 10.3109/13697137.2014.890180. Epub 2014 Mar 8.

 

Progestogens in postmenopausal hormone therapy and the risk of breast cancer.

Lambrinoudaki I.

Maturitas. 2014 Apr;77(4):311-7. doi: 10.1016/j.maturitas.2014.01.001. Epub 2014 Jan 9. Review.

 

Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor- κ B Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus.

Lambrinoudaki I, Tsouvalas E, Vakaki M, Kaparos G, Stamatelopoulos K, Augoulea A, Pliatsika P, Alexandrou A, Creatsa M, Karavanaki K.

Int J Endocrinol. 2013;2013:102120. doi: 10.1155/2013/102120. Epub 2013 Oct 30.

 

EMAS position statement: Fertility preservation.

Mintziori G, Lambrinoudaki I, Ceausu I, Depypere H, Erel CT, Pérez-López FR, Schenck-Gustafsson K, van der Schouw YT, Simoncini T, Tremollieres F, Tarlatzis BC, Rees M, Goulis DG.

Maturitas. 2014 Jan;77(1):85-9. doi: 10.1016/j.maturitas.2013.10.010. Epub 2013 Oct 25.

 

Cross-sectional long-term micronutrient deficiencies after sleeve gastrectomy versus Roux-en-Y gastric bypass: a pilot study.

Alexandrou A, Armeni E, Kouskouni E, Tsoka E, Diamantis T, Lambrinoudaki I.

Surg Obes Relat Dis. 2014 Mar-Apr;10(2):262-8. doi: 10.1016/j.soard.2013.07.014. Epub 2013 Aug 12.

 

Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.

Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.

J Hypertens. 2013 Oct;31(10):1998-2004. doi: 10.1097/HJH.0b013e3283630362. Erratum in: J Hypertens. 2014 Mar;32(3):702.

 

EMAS position statement: Late parenthood.

Mintziori G, Lambrinoudaki I, Kolibianakis EM, Ceausu I, Depypere H, Erel CT, Pérez-López FR, Schenck-Gustafsson K, van der Schouw Y, Simoncini T, Tremollieres F, Tarlatzis BC, Rees M, Goulis DG.

Maturitas. 2013 Oct;76(2):200-4. doi: 10.1016/j.maturitas.2013.07.008. Epub 2013 Aug 6.

 

EMAS clinical guide: assessment of the endometrium in peri and postmenopausal women.

Dreisler E, Poulsen LG, Antonsen SL, Ceausu I, Depypere H, Erel CT, Lambrinoudaki I, Pérez-López FR, Simoncini T, Tremollieres F, Rees M, Ulrich LG; European Menopause and Andropause Society.

Maturitas. 2013 Jun;75(2):181-90. doi: 10.1016/j.maturitas.2013.03.011. Epub 2013 Apr 22.

 

Efficacy and safety of DT56a compared to hormone therapy in Greek post-menopausal women.

Labos G, Trakakis E, Pliatsika P, Augoulea A, Vaggopoulos V, Basios G, Simeonidis G, Creatsa M, Alexandrou A, Iliodromiti Z, Kassanos D, Lambrinoudaki I.

J Endocrinol Invest. 2013 Jul-Aug;36(7):521-6. doi: 10.3275/8926. Epub 2013 Apr 8.

 

Osteoprotegerin as a marker of atherosclerosis in diabetic patients.

Augoulea A, Vrachnis N, Lambrinoudaki I, Dafopoulos K, Iliodromiti Z, Daniilidis A, Varras M, Alexandrou A, Deligeoroglou E, Creatsas G.

Int J Endocrinol. 2013;2013:182060. doi: 10.1155/2013/182060. Epub 2013 Jan 17.

 

EMAS clinical guide: Vulvar lichen sclerosus in peri and postmenopausal women.

Pérez-López FR, Ceasu I, Depypere H, Erel CT, Lambrinoudaki I, Rees M, Schenck-Gustafsson K, Tremollieres F, van der Schouw YT, Simoncini T. Maturitas. 2013 Jan 3. doi:pii: S0378-5122(12)00406-9. 10.1016/j.maturitas.2012.12.006. [Epub ahead of print]

 

Hormone therapy and the prevention of cardiovascular disease and cognitive decline: Where do we stand?

Lambrinoudaki I, Pérez-López FR. Maturitas. 2013 Feb;74(2):107-8. doi: 10.1016/j.maturitas.2012.11.008. Epub 2012 Dec 21. No abstract available.

 

Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.

Lambrinoudaki I, Patikas E, Kaparos G, Armeni E, Rizos D, Thoda P, Alexandrou A, Antoniou A, Tsivgoulis G, Gatzonis S, Panoulis C, Triantafyllou N. Neurol Sci. 2012 Dec 5. [Epub ahead of print]

 

EMAS position statement: Diet and health in midlife and beyond.

Lambrinoudaki I, Ceasu I, Depypere H, Erel T, Rees M, Schenck-Gustafsson K, Simoncini T, Tremollieres F, van der Schouw YT, Pérez-López FR. Maturitas. 2013 Jan;74(1):99-104. doi: 10.1016/j.maturitas.2012.10.019. Epub 2012 Nov 28.

 

MTHFR C677T polymorphism modifies the effect of HRT on metabolic parameters in postmenopausal women.

Lambrinoudaki I, Papadimitriou D, Kaparos G, Rizos D, Panoulis C, Deligeoroglou E, Alexandrou A, Auguolea A, Apostolakis M, Creatsa M, Kouskouni E. Climacteric. 2012 Nov 12. [Epub ahead of print]

 

Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors.

Grigoriou V, Augoulea A, Armeni E, Rizos D, Alexandrou A, Dendrinos S, Panoulis K, Lambrinoudaki I. Gynecol Endocrinol. 2013 Feb;29(2):125-8. doi: 10.3109/09513590.2012.708801. Epub 2012 Jul 31.

 

Can premenstrual syndrome affect arterial stiffness or blood pressure?

Stamatelopoulos KS, Georgiopoulos G, Papaioannou T, Lambrinoudaki I, Kouzoupis A, Vlachopoulos C, Georgiou SP, Manios E, Alevizaki M, Papamichael CM, Sfikakis PP. Atherosclerosis. 2012 Sep;224(1):170-6. doi: 10.1016/j.atherosclerosis.2012.05.037. Epub 2012 Jul 20.

 

EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy.

Rees M, Pérez-López FR, Ceasu I, Depypere H, Erel T, Lambrinoudaki I, Schenck-Gustafsson K, Simoncini T, van der Schouw Y, Tremollieres F. Maturitas. 2012 Oct;73(2):171-4. doi: 10.1016/j.maturitas.2012.06.009. Epub 2012 Jul 20.

 

Effect of tibolone and raloxifene on serum markers of apoptosis in postmenopausal women.

Lambrinoudaki I, Karaflou M, Kaparos G, Alexandrou A, Creatsa M, Aravantinos L, Augoulea A, Kouskouni E. Climacteric. 2012 May 29. [Epub ahead of print]

 

Recommendations on the management of fragility fracture risk in women younger than 70 years.

Palacios S, Christiansen C, Sánchez Borrego R, Gambacciani M, Hadji P, Karsdal M, Lambrinoudaki I, Lello S, O’Beirne B, Romao F, Rozenberg S, Stevenson JC, Ben-Rafael Z. Gynecol Endocrinol. 2012 Oct;28(10):770-86. doi: 10.3109/09513590.2012.679062. Epub 2012 May 7.

 

Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress.

Augoulea A, Alexandrou A, Creatsa M, Vrachnis N, Lambrinoudaki I. Arch Gynecol Obstet. 2012 Jul;286(1):99-103. doi: 10.1007/s00404-012-2357-8. Epub 2012 May 1. Review.

 

Previous gestational diabetes mellitus and markers of cardiovascular risk.

Vrachnis N, Augoulea A, Iliodromiti Z, Lambrinoudaki I, Sifakis S, Creatsas G.

Int J Endocrinol. 2012;2012:458610. doi: 10.1155/2012/458610. Epub 2012 Mar 18.

 

Serum lipid levels and bone mineral density in Greek postmenopausal women.

Pliatsika P, Antoniou A, Alexandrou A, Panoulis C, Kouskouni E, Augoulea A, Dendrinos S, Aravantinos L, Creatsa M, Lambrinoudaki I. Gynecol Endocrinol. 2012 Aug;28(8):655-60. doi: 10.3109/09513590.2011.650766. Epub 2012 Feb 10.

 

High normal thyroid-stimulating hormone is associated with arterial stiffness in healthy postmenopausal women.

Lambrinoudaki I, Armeni E, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Deligeoroglou E, Livada A, Psychas C, Creatsa M, Bouboulis G, Alevizaki M, Stamatelopoulos K. J Hypertens. 2012 Mar;30(3):592-9. doi: 10.1097/HJH.0b013e32834f5076.

 

Recently postmenopausal women have the same prevalence of subclinical carotid atherosclerosis as age and traditional risk factor matched men.

Stamatelopoulos KS, Armeni E, Georgiopoulos G, Kazani M, Kyrkou K, Stellos K, Koliviras A, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I. Atherosclerosis. 2012 Apr;221(2):508-13. doi: 10.1016/j.atherosclerosis.2011.12.006. Epub 2011 Dec 9.

 

Determinants of quality of life in Greek middle-age women: a population survey.

Giannouli P, Zervas I, Armeni E, Koundi K, Spyropoulou A, Alexandrou A, Kazani A, Areti A, Creatsa M, Lambrinoudaki I. Maturitas. 2012 Feb;71(2):154-61. doi: 10.1016/j.maturitas.2011.11.013. Epub 2011 Dec 16.

 

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.

Palacios S, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rees M, Rozenberg S. Maturitas. 2012 Feb;71(2):194-8. doi: 10.1016/j.maturitas.2011.11.010. Epub 2011 Dec 15. Review.

 

Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women.

Lambrinoudaki I, Augoulea A, Armeni E, Rizos D, Alexandrou A, Creatsa M, Kazani M, Georgiopoulos G, Livada A, Exarchakou A, Stamatelopoulos K. Climacteric. 2012 Aug;15(4):350-7. doi: 10.3109/13697137.2011.618564. Epub 2011 Dec 1.

 

EMAS position statement: Vitamin D and postmenopausal health.

Pérez-López FR, Brincat M, Erel CT, Tremollieres F, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Vujovic S, Rozenberg S, Rees M. Maturitas. 2012 Jan;71(1):83-8. doi: 10.1016/j.maturitas.2011.11.002. Epub 2011 Nov 17.

 

Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?

Sioulas VD, Politi E, Rizos D, Augoulea A, Kyroudi A, Sergentanis TN, Panoulis C, Aravantinos L, Creatsa M, Lambrinoudaki I. Climacteric. 2012 Apr;15(2):181-5. doi: 10.3109/13697137.2011.604144. Epub 2011 Nov 8.

 

Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis.

Triantafyllou N, Lambrinoudaki I, Thoda P, Andreadou E, Kararizou E, Alexandrou A, Limouris G, Antoniou A, Tsivgoulis G. J Neurol Sci. 2012 Feb 15;313(1-2):137-41. doi: 10.1016/j.jns.2011.09.002. Epub 2011 Oct 10.

 

Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women.

Creatsa M, Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Dendrinos S, Augoulea A, Papamichael C, Lambrinoudaki I. Metabolism. 2012 Feb;61(2):193-201. doi: 10.1016/j.metabol.2011.06.005. Epub 2011 Aug 4.

 

Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk.

Lambrinoudaki I, Armeni E, Georgiopoulos G, Kazani M, Kouskouni E, Creatsa M, Alexandrou A, Fotiou S, Papamichael C, Stamatelopoulos K. Int J Cardiol. 2011 Jul 5. [Epub ahead of print]

 

The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study.

Creatsa M, Pliatsika P, Kaparos G, Antoniou A, Armeni E, Tsakonas E, Panoulis C, Alexandrou A, Dimitraki E, Christodoulakos G, Lambrinoudaki I. J Obstet Gynaecol Res. 2011 Oct;37(10):1415-22.

 

EMAS position statement: Managing menopausal women with a personal or family history of VTE.

Tremollieres F, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Vujovic S, Rozenberg S, Rees M. Maturitas. 2011 Jun;69(2):195-8. Epub 2011 Apr 12.

 

Sp1 collagen I A1 polymorphism in women with stress urinary incontinence.

Sioutis D, Economou E, Lambrinoudaki I, Tsamadias V, Creatsa M, Liapis A. Int Urogynecol J. 2011 Jul;22(7):835-9. Epub 2011 Feb 19.

 

EMAS position statement: Managing the menopause in the context of coronary heart disease.

Schenck-Gustafsson K, Brincat M, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Tremollieres F, Vujovic S, Rozenberg S, Rees M; EMAS. Maturitas. 2011 Jan;68(1):94-7. Epub 2010 Dec 14. Erratum in: Maturitas. 2011 Jun;69(2):e6.

 

EMAS position statement: Bone densitometry screening for osteoporosis.

Brincat M, Calleja-Agius J, Erel CT, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rees M, Rozenberg S; EMAS. Maturitas. 2011 Jan;68(1):98-101. Epub 2010 Nov 19. Erratum in: Maturitas. 2011 Jun;69(2):e5.

 

Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women.

Vitoratos N, Lambrinoudaki I, Rizos D, Armeni E, Alexandrou A, Creatsas G. Eur J Obstet Gynecol Reprod Biol. 2011 Feb;154(2):141-5. Epub 2010 Nov 11.

 

The frequency of early, spontaneous miscarriage associated with the leu33pro polymorphism of Glycoprotein IIIa: a pilot study.

Lambrinoudaki I, Armeni E, Kaparos GJ, Christodoulakos GE, Sergentanis TN, Alexandrou A, Creatsa M, Kouskouni E. Aust N Z J Obstet Gynaecol. 2010 Oct;50(5):485-90. doi: 10.1111/j.1479-828X.2010.01196.x.

 

Sex hormones in postmenopausal women receiving low-dose hormone therapy: the effect of BMI.

Lambrinoudaki I, Armeni E, Rizos D, Deligeoroglou E, Kofinakos P, Kaparos G, Alexandrou A, Creatsa M, Logothetis E, Kouskouni E. Obesity (Silver Spring). 2011 May;19(5):988-93. Epub 2010 Oct 14.

 

Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.

Lambrinoudaki  I. Maturitas. 2011 Jan;68(1):13-6. Epub 2010 Oct 12. Review.

 

Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment. Lambrinoudaki I, Vlachou SA, Creatsas G. Curr Diabetes Rev. 2010 Nov;6(6):393-9. Review.

 

Pathophysiology of bone loss in the female athlete.

Lambrinoudaki I, Papadimitriou D. Ann N Y Acad Sci. 2010 Sep;1205:45-50. doi: 10.1111/j.1749-6632.2010.05681.x. Review.

 

Reproductive hormones and postpartum mood disturbances in Greek women.

Chatzicharalampous C, Rizos D, Pliatsika P, Leonardou A, Hasiakos D, Zervas I, Alexandrou A, Creatsa M, Konidaris S, Lambrinoudaki I. Gynecol Endocrinol. 2011 Aug;27(8):543-50. Epub 2010 Jul 23.

 

Androgens associated with advanced glycation end-products in postmenopausal women.

Diamanti-Kandarakis E, Lambrinoudaki I, Economou F, Christou M, Piperi C, Papavassiliou AG, Creatsas G. Menopause. 2010 Nov-Dec;17(6):1182-7.

 

EMAS position statement: Managing the menopause in women with a past history of endometriosis.

Moen MH, Rees M, Brincat M, Erel T, Gambacciani M, Lambrinoudaki I, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rozenberg S; European Menopause and Andropause Society. Maturitas. 2010 Sep;67(1):94-7.

 

EMAS position statement: Managing women with premature ovarian failure.

Vujovic S, Brincat M, Erel T, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Rozenberg S, Rees M; European Menopause and Andropause Society. Maturitas. 2010 Sep;67(1):91-3. Epub 2010 Jun 3. Erratum in: Maturitas. 2011 Jun;69(2):e4.

 

BsmI vitamin D receptor’s polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.

Lambrinoudaki I, Kaparos G, Armeni E, Alexandrou A, Damaskos C, Logothetis E, Creatsa M, Antoniou A, Kouskouni E, Triantafyllou N. Eur J Neurol. 2011 Jan;18(1):93-8. doi: 10.1111/j.1468-1331.2010.03103.x.

 

Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women.

Karaflou M, Kaparos G, Rizos D, Creatsa M, Christodoulakos G, Lambrinoudaki I. Fertil Steril. 2010 Nov;94(6):2399-401. Epub 2010 May 20.

 

The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.

Lambrinoudaki I, Karaflou M, Kaparos G, Grigoriou O, Alexandrou A, Panoulis C, Logothetis E, Creatsa M, Christodoulakos G, Kouskouni E. J Endocrinol Invest. 2010 Nov;33(10):720-4. Epub 2010 Apr 30.

 

EMAS position statement: managing obese postmenopausal women.

Lambrinoudaki I, Brincat M, Erel CT, Gambacciani M, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rees M, Rozenberg S.

Maturitas. 2010 Jul;66(3):323-6.

 

EMAS position statement: managing the menopause in women with epilepsy.

Erel CT, Brincat M, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rozenberg S, Rees M.

Maturitas. 2010 Jul;66(3):327-8. Epub 2010 Apr 24.

 

Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy.

Triantafyllou N, Lambrinoudaki I, Armeni E, Evangelopoulos EM, Boufidou F, Antoniou A, Tsivgoulis G. J Neurol Sci. 2010 Mar 15;290(1-2):131-4. Epub 2010 Jan

 

Arterial wave reflections during the menstrual cycle of healthy women: a reproducibility study.

Papaioannou TG, Stamatelopoulos KS, Georgiopoulos G, Vlachopoulos C, Georgiou S, Lykka M, Lambrinoudaki I, Papamichael CM, Stefanadis CI.

Hypertension. 2009 Nov;54(5):1021-7. Epub 2009 Sep 8.

 

Endometriosis and other benign and malignant müllerian lesions in pelvic and extrapelvic organs.

Lambrinoudaki I, Augoulea A, Creatsa M, Vlachos N, Christodoulakos G, Papadias C. Anal Quant Cytol Histol. 2009 Jun;31(3):170-6.

 

Thyroid function and postpartum mood disturbances in Greek women.

Lambrinoudaki I, Rizos D, Armeni E, Pliatsika P, Leonardou A, Sygelou A, Argeitis J, Spentzou G, Hasiakos D, Zervas I, Papadias C. J Affect Disord. 2010 Mar;121(3):278-82. Epub 2009 Jul 25.

 

Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors.

Georgiopoulos GA, Stamatelopoulos KS, Lambrinoudaki I, Lykka M, Kyrkou K, Rizos D, Creatsa M, Christodoulakos G, Alevizaki M, Sfikakis PP, Papamichael C.

Hypertension. 2009 Jul;54(1):98-105. Epub 2009 May 18.

 

Progestin may modify the effect of low-dose hormone therapy on mammographic breast density.

Panoulis C, Lambrinoudaki I, Vourtsi A, Augoulea A, Kaparos G, Aravantinos L, Christodoulakos G, Creatsas G. Climacteric. 2009 Jun;12(3):240-7.

 

The role of the oxidative-stress in the endometriosis-related infertility.

Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G.

Gynecol Endocrinol. 2009 Feb;25(2):75-81. Review.

 

Irritability in Menopause: An Investigation of Its Relation to Menopausal, Hormonal and Physical Factors.

Spyropoulou AC, Zervas IM, Christodoulakos G, Lambrinoudaki I, Rizos D, Koundi K, Sanida E, Creatsas G, Soldatos CR.

Psychother Psychosom. 2009 Feb 18;78(2):128-130.

 

Additive effect of depressed mood and vasomotor symptoms on postmenopausal insomnia.

Zervas IM, Lambrinoudaki I, Spyropoulou AC, Koundi KL, Voussoura E, Tzavara C, Verdeli H, Aravantinos L, Creatsa M, Paparrigopoulos T.

Menopause. 2009 Jul-Aug;16(4):837-42.

 

Apolipoprotein E and Paraoxonase 1 polymorphisms are associated with lower serum thyroid hormones in postmenopausal women.

Lambrinoudaki I, Kaparos G, Rizos D, Galapi F, Alexandrou A, Sergentanis TN, Creatsa M, Christodoulakos G, Kouskouni E, Botsis D.

Clin Endocrinol (Oxf). 2008 Aug;71(2):284-90.

 

Parity is associated with lower cervical E-cadherin expression in postmenopausal women.

Sioulas V, Lambrinoudaki I, Politi E, Kyroudi A, Sergentanis TN, Panoulis C, Augoulea A, Kaparos G, Creatsa M, Koutselini H, Papadias K.

J Obstet Gynaecol Res. 2008 Dec;34(6):1043-8.

 

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women.

Lambrinoudaki I, Vlachou S, Galapi F, Papadimitriou D, Papadias K.

Clin Interv Aging. 2008;3(3):445-51. Review.

 

Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women.

Lambrinoudaki I, Kaparos G, Papadimitriou D, Sergentanis TN, Creatsa M, Alexandrou A, Logothetis E, Christodoulakos G, Kouskouni E.

Eur J Endocrinol. 2008 Sep;159(3):233-41.

 

CSF and plasma cytokines at delivery and postpartum mood disturbances.

Boufidou F, Lambrinoudaki I, Argeitis J, Zervas IM, Pliatsika P, Leonardou AA, Petropoulos G, Hasiakos D, Papadias K, Nikolaou C.

J Affect Disord 2009 May;115(1-2):287-92.

 

Apoptosis in atherosclerosis: a mini-review.

Karaflou M, Lambrinoudaki I, Christodoulakos G.

Mini Rev Med Chem. 2008 Aug;8(9):912-8. Review.

 

CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women.

Lambrinoudaki IV, Kaparos GI, Vlachou SA, Stamatelopoulos KS, Georgiopoulos GA, Sergentanis TN, Panoulis CP, Christodoulakos GE, Alexandrou AP, Kouskouni EE, Creatsa MG, Papamichael CM.

Menopause. 2008 Nov-Dec;15(6):1163-8.

 

Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.

Christodoulakos GE, Lambrinoudaki IV, Creatsa MG, Economou EV, Siasou Z, Panoulis CP, Kalligerou I, Papadias C.

Climacteric. 2008 Apr;11(2):155-65.

 

Measurable serum markers of oxidative stress response in women with endometriosis.

Lambrinoudaki IV, Augoulea A, Christodoulakos GE, Economou EV, Kaparos G, Kontoravdis A, Papadias C, Creatsas G.

Fertil Steril. 2009 Jan;91(1):46-50.

 

Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.

Lambrinoudaki IV, Christodoulakos GE, Economou EV, Vlachou SA, Panoulis CP, Alexandrou AP, Kouskouni EE, Creatsas GC.

Maturitas. 2008 Jan 20;59(1):62-71.

 

The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.

Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.

Climacteric. 2007 Oct;10(5):400-7.

 

Pathogenesis of endometriosis: the role of defective ‘immunosurveillance’.

Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V, Creatsas G.

Eur J Contracept Reprod Health Care. 2007 Sep;12(3):194-202. Review.

 

E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone, and raloxifene.

Sioulas V, Christodoulakos G, Lambrinoudaki I, Politi E, Sergentanis TN, Creatsas G.

Fertil Steril. 2008 Apr;89(4):1018-20.

 

Thoracic endometriosis syndrome.

Augoulea A, Lambrinoudaki I, Christodoulakos G.

Respiration. 2008;75(1):113-9. Review.

 

Ovarian endometriosis associated with ovarian cancer and endometrial-endocervical polyps.

Kontoravdis A, Augoulea A, Lambrinoudaki I, Christodoulakos G, Tzortziotis D, Grammatikakis I, Kontoravdis N, Creatsas G.

J Obstet Gynaecol Res. 2007 Jun;33(3):294-8.

 

Bisphosphonates.

Lambrinoudaki I, Christodoulakos G, Botsis D.

Ann N Y Acad Sci. 2006 Dec;1092:397-402. Review.

 

The cardiovascular effects of selective estrogen receptor modulators.

Christodoulakos GE, Lambrinoudaki IV, Botsis DC.

Ann N Y Acad Sci. 2006 Dec;1092:374-84. Review.

 

Quality of life and psychological symptoms in Greek postmenopausal women: association with hormone therapy.

Koundi KL, Christodoulakos GE, Lambrinoudaki IV, Zervas IM, Spyropoulou A, Fexi P, Sakkas PN, Soldatos CR, Creatsas GC. Gynecol Endocrinol. 2006 Dec;22(12):660-8.

 

Polycystic ovary syndrome in adolescents: current and future treatment options.

Mastorakos G, Lambrinoudaki I, Creatsas G.

Paediatr Drugs. 2006;8(5):311-8. Review.

 

Macroprolactinemia. Is treatment necessary?

Lambrinoudaki IV, Daskalaki OD, Thomopoulos SA, Schinochoritis P, Argyropoulos AB.

Hormones (Athens). 2003 Jul-Sep;2(3):183-5.

 

Body composition in asymptomatic HIV-infected men: cross-sectional and prospective assessment.

Lazanas MC, Lambrinoudaki IV, Douskas GA, Tsekes GA, Chini MN, Georgiou EK.

Hormones (Athens). 2003 Jan-Mar;2(1):43-8.

 

Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.

Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Vitoratos N, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.

Atherosclerosis. 2007 Jul;193(1):142-50. Epub 2006 Jul 13.

 

Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women.

Lambrinoudaki I, Christodoulakos G, Rizos D, Economou E, Argeitis J, Vlachou S, Creatsa M, Kouskouni E, Botsis D.

Eur J Endocrinol. 2006 Jun;154(6):907-16.

 

Endogenous sex steroids and circulating homocysteine in healthy Greek postmenopausal women.

Christodoulakos GE, Lambrinoudaki IV, Rizos DA, Alexandrou A, Kountouris AV, Creatsas GC.

Hormones (Athens). 2006 Jan-Mar;5(1):35-41.

 

Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma.

Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.

J Cardiovasc Pharmacol. 2006 Apr;47(4):542-8.

 

Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women.

Lambrinoudaki I, Christodoulakos G, Aravantinos L, Antoniou A, Rizos D, Chondros C, Kountouris A, Chrysofakis G, Creatsas G.

J Bone Miner Metab. 2006;24(1):65-71.

 

The effect of low dose hormone therapy on mammographic breast density.

Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, Vlachou S, Creatsa M, Panoulis KP, Botsis D.

Maturitas. 2006 Apr 20;54(1):78-85.

 

The effect of raloxifene and tibolone on the uterine blood flow and endometrial thickness: a transvaginal Doppler study.

Botsis D, Christodoulakos G, Papagianni V, Lambrinoudaki I, Aravantinos L, Makrakis E, Creatsas G.

Maturitas. 2006 Feb 20;53(3):362-8.

 

A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.

Christodoulakos GE, Botsis DS, Lambrinoudaki IV, Papagianni VD, Panoulis CP, Creatsa MG, Alexandrou AP, Augoulea AD, Dendrinos SG, Creatsas GC.

Maturitas. 2006 Mar 20;53(4):413-23.

 

Cardiovascular disease: screening and management of the a-symptomatic high-risk post-menopausal woman.

Creatsas G, Christodoulakos G, Lambrinoudaki I.

Maturitas. 2005 Nov 15;52 Suppl 1:S32-7. Epub 2005 Sep 2. Review.

 

Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels.

Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G.

Gynecol Endocrinol. 2005 Apr;20(4):227-35. Review.

 

Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women.

Tentolouris N, Christodoulakos G, Lambrinoudaki I, Mandalaki E, Panoulis C, Maridaki C, Creatsas G, Katsilambros N.

J Endocrinol Invest. 2005 Apr;28(4):305-11.

 

Effect of oral contraceptive treatment on bone mass acquisition in skeletally immature young female rats.

Eleftheriades MI, Lambrinoudaki IV, Christodoulakos GE, Gregoriou OV, Economou EV, Kouskouni EE, Antoniou AG, Perrea DN, Dontas IA, Raptou PD, Lyritis GP, Creatsas GC.

Contraception. 2005 May;71(5):362-71.

 

Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.

Maturitas. 2005 Apr 11;50(4):321-30.

 

Effect of hormone therapy and raloxifene on serum VE-cadherin in postmenopausal women.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Papadias C, Economou E, Creatsas G.

Fertil Steril. 2004 Sep;82(3):634-8.

 

Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.

Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC.

Gynecol Endocrinol. 2004 May;18(5):244-57.

 

Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Papadias C, Sarandakou A, Liakakos T, Alexandrou A, Creatsas G.

Eur J Endocrinol. 2004 Aug;151(2):187-92.

 

Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.

Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.

Maturitas. 2004 Jun 15;48(2):107-13.

 

The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women.

Christodoulakos GE, Panoulis CP, Lambrinoudaki IV, Botsis DS, Dendrinos SG, Economou E, Creatsas GC.

Menopause. 2004 May-Jun;11(3):299-305.

 

Determinants of serum leptin levels in healthy postmenopausal women.

Lambrinoudaki I, Christodoulakos G, Panoulis C, Botsis D, Rizos D, Augoulea A, Creatsas G.

J Endocrinol Invest. 2003 Dec;26(12):1225-30.

 

Effect of hormone replacement therapy and tibolone on serum total homocysteine levels in postmenopausal women.

Christodoulakos GE, Panoulis CP, Lambrinoudaki IV, Dendrinos SG, Rizos DA, Creatsas GC.

Eur J Obstet Gynecol Reprod Biol. 2004 Jan 15;112(1):74-9.

 

Serum lipids and apolipoproteins in Greek postmenopausal women: association with estrogen, estrogen-progestin, tibolone and raloxifene therapy.

Creatsas G, Christodoulakos G, Lambrinoudaki I, Panoulis C, Chondros C, Patramanis P.

J Endocrinol Invest. 2003 Jun;26(6):545-51.

 

The effect of various regimens of hormone replacement therapy on mammographic breast density.

Christodoulakos GE, Lambrinoudaki IV, Panoulis KP, Vourtsi AD, Vlachos L, Georgiou E, Creatsas GC.

Maturitas. 2003 Jun 30;45(2):109-18.

 

Effect of raloxifene, estrogen, and hormone replacement therapy on serum homocysteine levels in postmenopausal women.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Rizos D, Coutoukos J, Creatsas G.

Fertil Steril. 2003 Feb;79(2):455-6. No abstract available.

 

Breast pain and mammographic density increase as a consequence of raloxifene therapy.

Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, Panoulis KP, Creatsas GC.

J Endocrinol Invest. 2002 Jun;25(6):564-6.

 

Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study.

Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, Panoulis KP, Kelekis DA, Creatsas GC.

Menopause. 2002 Mar-Apr;9(2):110-6.

 

Management of steroid-induced osteoporosis.

Lambrinoudaki I, Kung AW.

Chin Med J (Engl). 2000 Aug;113(8):681-5. Review.

 

Absence of high-risk “s” allele associated with osteoporosis at the intronic SP1 binding-site of collagen Ialpha1 gene in Southern Chinese.

Lambrinoudaki I, Kung AW.

J Endocrinol Invest. 2001 Jul-Aug;24(7):499-502.

 

Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.

Lambrinoudaki I, Chan DT, Lau CS, Wong RW, Yeung SS, Kung AW.

J Rheumatol. 2000 Jul;27(7):1759-65.

 

Body composition assessment by dual-energy x-ray absorptiometry: comparison of prone and supine measurements.

Lambrinoudaki I, Georgiou E, Douskas G, Tsekes G, Kyriakidis M, Proukakis C.

Metabolism. 1998 Nov;47(11):1379-82.

 

Body composition changes in chronic hemodialysis patients before and after hemodialysis as assessed by dual-energy x-ray absorptiometry.

Georgiou E, Virvidakis K, Douskas G, Lambrinoudaki I, Voudiklari S, Katsoudas S, Mountokalakis T, Proukakis C.

Metabolism. 1997 Sep;46(9):1059-62.

 

The SCH9 protein kinase mRNA contains a long 5′ leader with a small open reading frame.

di Blasi F, Carra E, de Vendittis E, Masturzo P, Burderi E, Lambrinoudaki I, Mirisola MG, Seidita G, Fasano O.

Yeast. 1993 Jan;9(1):21-32.